{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 821384, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:01:06Z", "timestamp": 1574488866832}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAMA"], "published-print": {"date-parts": [[2012, 7, 18]]}, "DOI": "10.1001/jama.2012.7625", "type": "journal-article", "created": {"date-parts": [[2012, 7, 17]], "date-time": "2012-07-17T23:00:53Z", "timestamp": 1342566053000}, "source": "Crossref", "is-referenced-by-count": 130, "title": ["Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis"], "prefix": "10.1001", "volume": "308", "author": [{"given": "Afsaneh", "family": "Shirani", "sequence": "first", "affiliation": []}, {"given": "Yinshan", "family": "Zhao", "sequence": "additional", "affiliation": []}, {"given": "Mohammad Ehsanul", "family": "Karim", "sequence": "additional", "affiliation": []}, {"given": "Charity", "family": "Evans", "sequence": "additional", "affiliation": []}, {"given": "Elaine", "family": "Kingwell", "sequence": "additional", "affiliation": []}, {"given": "Mia L.", "family": "van der Kop", "sequence": "additional", "affiliation": []}, {"given": "Joel", "family": "Oger", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Gustafson", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Petkau", "sequence": "additional", "affiliation": []}, {"given": "Helen", "family": "Tremlett", "sequence": "additional", "affiliation": []}], "member": "10", "container-title": ["JAMA"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jama/fullarticle/1217239", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T18:57:15Z", "timestamp": 1481828235000}, "score": 60.83423, "issued": {"date-parts": [[2012, 7, 18]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 7, 18]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1001/jama.2012.7625", "ISSN": ["0098-7484"], "issn-type": [{"value": "0098-7484", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:02:38Z", "timestamp": 1575104558077}, "reference-count": 18, "publisher": "SAGE Publications", "issue": "4", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2003, 8, 1]], "date-time": "2003-08-01T00:00:00Z", "timestamp": 1059696000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2003, 8]]}, "DOI": "10.1191/1352458503ms923oa", "type": "journal-article", "created": {"date-parts": [[2003, 11, 12]], "date-time": "2003-11-12T12:45:16Z", "timestamp": 1068641116000}, "page": "342-348", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a                 double-blind randomized study"], "prefix": "10.1177", "volume": "9", "author": [{"given": "C", "family": "Polman", "sequence": "first", "affiliation": [{"name": "Department of Neurology, Free University Medical Center, de Boelelaan                         1117, NL-1007 MB Amsterdam, the Netherlands,"}]}, {"given": "F", "family": "Barkhof", "sequence": "additional", "affiliation": [{"name": "Department of Radiology, Free University Medical Center, de Boelelaan                         1117, NL-1007 MB Amsterdam, the Netherlands"}]}, {"given": "L", "family": "Kappos", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, University Hospitals Basel, Petersgraben 4,                         CH-4031 Basel, Switzerland"}]}, {"given": "C", "family": "Pozzilli", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, University of Rome \u2018La                         Sapienza\u2019, Viale Universit\u00e0 30, I-00185 Roma, Italy;"}]}, {"given": "R", "family": "Sandbrink", "sequence": "additional", "affiliation": [{"name": "Schering AG, Sellerstr. 31, D-13342 Berlin, Germany"}]}, {"given": "F", "family": "Dahlke", "sequence": "additional", "affiliation": [{"name": "Schering AG, Sellerstr. 31, D-13342 Berlin, Germany"}]}, {"given": "P", "family": "Jakobs", "sequence": "additional", "affiliation": [{"name": "Schering AG, Sellerstr. 31, D-13342 Berlin, Germany"}]}, {"given": "A", "family": "Lorenz", "sequence": "additional", "affiliation": [{"name": "Rentschler Biotechnologie GmbH &amp; Co. KG, Erwin-Rentschler-Str.                         21, D-88471 Laupheim, Germany"}]}, {"name": "European Oral Interferon Beta-1a in Relapsing-Remitting MS Study Group", "sequence": "additional", "affiliation": []}], "member": "179", "published-online": {"date-parts": [[2016, 7, 2]]}, "reference": [{"key": "atypb1", "author": "Paty DW", "volume": "43", "first-page": "662", "year": "1993", "journal-title": "Neurology", "DOI": "10.1212/WNL.43.4.662", "doi-asserted-by": "crossref"}, {"key": "atypb2", "author": "PRISMS Study Group", "volume": "352", "first-page": "1498", "year": "1998", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(98)03334-0", "doi-asserted-by": "crossref"}, {"key": "atypb3", "author": "Miller DH", "volume": "46", "first-page": "850", "year": "1999", "journal-title": "Ann Neurol", "DOI": "10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q", "doi-asserted-by": "crossref"}, {"key": "atypb4", "author": "Li DK", "volume": "12", "first-page": "1505", "year": "2001", "journal-title": "Neurology"}, {"key": "atypb5", "author": "IFNB Multiple Sclerosis Study Group", "volume": "43", "first-page": "655", "year": "1993", "journal-title": "Neurology", "DOI": "10.1212/WNL.43.4.655", "doi-asserted-by": "crossref"}, {"key": "atypb6", "author": "Jacobs LD", "volume": "39", "first-page": "285", "year": "1996", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410390304", "doi-asserted-by": "crossref"}, {"key": "atypb7", "DOI": "10.3181/00379727-201-43499", "doi-asserted-by": "publisher"}, {"key": "atypb8", "author": "Brod SA", "volume": "44", "first-page": "1144", "year": "1994", "journal-title": "Neurology", "DOI": "10.1212/WNL.44.6.1144", "doi-asserted-by": "crossref"}, {"key": "atypb9", "author": "Brod SA", "volume": "58", "first-page": "61", "year": "1995", "journal-title": "J Neurol Immunol"}, {"key": "atypb10", "author": "Brod SA", "volume": "9", "first-page": "11", "year": "1996", "journal-title": "J Autoimmun", "DOI": "10.1006/jaut.1996.0003", "doi-asserted-by": "crossref"}, {"key": "atypb11", "DOI": "10.1177/135245859700300101", "doi-asserted-by": "publisher"}, {"key": "atypb12", "author": "Bocci V.", "volume": "21", "first-page": "274", "year": "1991", "journal-title": "Clin Pharmacokinet", "DOI": "10.2165/00003088-199121040-00004", "doi-asserted-by": "crossref"}, {"key": "atypb13", "author": "Georgiades JA", "volume": "8", "first-page": "205", "year": "1996", "journal-title": "Biotherapy", "DOI": "10.1007/BF01877206", "doi-asserted-by": "crossref"}, {"key": "atypb14", "author": "Vriesendorp FJ", "volume": "24", "first-page": "157", "year": "1997", "journal-title": "Autoimmunity", "DOI": "10.3109/08916939608995361", "doi-asserted-by": "crossref"}, {"key": "atypb15", "author": "Witt PL", "volume": "12", "first-page": "411", "year": "1992", "journal-title": "J Interferon Res", "DOI": "10.1089/jir.1992.12.411", "doi-asserted-by": "crossref"}, {"key": "atypb16", "author": "Poser CM", "volume": "13", "first-page": "227", "year": "1983", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410130302", "doi-asserted-by": "crossref"}, {"key": "atypb17", "author": "Kurtzke JF.", "volume": "5", "first-page": "580", "year": "1955", "journal-title": "Neurology", "DOI": "10.1212/WNL.5.8.580", "doi-asserted-by": "crossref"}, {"key": "atypb18", "author": "Brod SA", "volume": "57", "first-page": "845", "year": "2001", "journal-title": "Neurology", "DOI": "10.1212/WNL.57.5.845", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458503ms923oa", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458503ms923oa", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T07:54:36Z", "timestamp": 1556783676000}, "score": 50.832294, "issued": {"date-parts": [[2003, 8]]}, "references-count": 18, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 2]]}, "published-print": {"date-parts": [[2003, 8]]}, "issue": "4"}, "alternative-id": ["10.1191/1352458503ms923oa"], "URL": "http://dx.doi.org/10.1191/1352458503ms923oa", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}], "subject": ["Neurology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T22:27:02Z", "timestamp": 1574375222601}, "reference-count": 10, "publisher": "SAGE Publications", "issue": "4", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2008, 1, 21]], "date-time": "2008-01-21T00:00:00Z", "timestamp": 1200873600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2008, 5]]}, "DOI": "10.1177/1352458507085758", "type": "journal-article", "created": {"date-parts": [[2008, 6, 18]], "date-time": "2008-06-18T15:40:49Z", "timestamp": 1213803649000}, "page": "553-556", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Multimodal evoked potentials measure and predict disability progression in                 early relapsing\u2013remitting multiple sclerosis"], "prefix": "10.1177", "volume": "14", "author": [{"given": "P", "family": "Jung", "sequence": "first", "affiliation": [{"name": "Department of Neurology, Johann Wolfgang Goethe-University, Frankfurt am                         Main, Germany,"}]}, {"given": "A", "family": "Beyerle", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, Johann Wolfgang Goethe-University, Frankfurt am                         Main, Germany"}]}, {"given": "U", "family": "Ziemann", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, Johann Wolfgang Goethe-University, Frankfurt am                         Main, Germany"}]}], "member": "179", "published-online": {"date-parts": [[2008, 1, 21]]}, "reference": [{"key": "atypb1", "author": "Dutta R", "volume": "68", "first-page": "S22", "year": "2007", "journal-title": "Neurology", "DOI": "10.1212/01.wnl.0000275229.13012.32", "doi-asserted-by": "crossref"}, {"key": "atypb2", "author": "O'Connor P", "volume": "44", "first-page": "404", "year": "1998", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410440320", "doi-asserted-by": "crossref"}, {"key": "atypb3", "author": "Fuhr P", "volume": "124", "first-page": "2162", "year": "2001", "journal-title": "Brain", "DOI": "10.1093/brain/124.11.2162", "doi-asserted-by": "crossref"}, {"key": "atypb4", "author": "Leocani L", "volume": "77", "first-page": "1030", "year": "2006", "journal-title": "J Neurol Neurosurg Psychiatry", "DOI": "10.1136/jnnp.2005.086280", "doi-asserted-by": "crossref"}, {"key": "atypb5", "author": "Deuschl G", "volume": "52", "first-page": "53", "year": "1999", "journal-title": "Electroencephalogr Clin Neurophysiol"}, {"key": "atypb6", "author": "Jung P", "volume": "250", "first-page": "133", "year": "2006", "journal-title": "J Neurol Sci", "DOI": "10.1016/j.jns.2006.08.008", "doi-asserted-by": "crossref"}, {"key": "atypb7", "author": "Claus D", "volume": "13", "first-page": "1125", "year": "1990", "journal-title": "Muscle Nerve", "DOI": "10.1002/mus.880131207", "doi-asserted-by": "crossref"}, {"key": "atypb8", "author": "St\u00f6hr M", "first-page": "23", "year": "1996", "volume-title": "Evozierte Potentiale.", "DOI": "10.1007/978-3-662-07146-5_2", "doi-asserted-by": "crossref"}, {"key": "atypb9", "DOI": "10.1191/135248506ms1244oa", "doi-asserted-by": "publisher"}, {"key": "atypb10", "author": "Schmierer K", "volume": "68", "first-page": "633", "year": "2000", "journal-title": "J Neurol Neurosurg Psychiatry", "DOI": "10.1136/jnnp.68.5.633", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1352458507085758", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1352458507085758", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T07:42:39Z", "timestamp": 1556782959000}, "score": 48.51061, "issued": {"date-parts": [[2008, 1, 21]]}, "references-count": 10, "journal-issue": {"published-online": {"date-parts": [[2008, 1, 21]]}, "published-print": {"date-parts": [[2008, 5]]}, "issue": "4"}, "alternative-id": ["10.1177/1352458507085758"], "URL": "http://dx.doi.org/10.1177/1352458507085758", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:07:53Z", "timestamp": 1574158073507}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000, 3, 1]]}, "DOI": "10.1001/archneur.57.3.425", "type": "journal-article", "created": {"date-parts": [[2003, 3, 18]], "date-time": "2003-03-18T19:38:01Z", "timestamp": 1048016281000}, "page": "425-426", "source": "Crossref", "is-referenced-by-count": 1, "title": ["How Does One Define Progression of Disease in Patients With Relapsing-Remitting Multiple Sclerosis?"], "prefix": "10.1001", "volume": "57", "author": [{"given": "R. A.", "family": "Rudick", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["Archives of Neurology"], "deposited": {"date-parts": [[2007, 2, 13]], "date-time": "2007-02-13T20:56:13Z", "timestamp": 1171400173000}, "score": 48.136032, "issued": {"date-parts": [[2000, 3, 1]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1001/archneur.57.3.425", "ISSN": ["0003-9942"], "issn-type": [{"value": "0003-9942", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:47:25Z", "timestamp": 1574801245347}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 5, 1]], "date-time": "2016-05-01T00:00:00Z", "timestamp": 1462060800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2017, 5, 1]], "date-time": "2017-05-01T00:00:00Z", "timestamp": 1493596800000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Value in Health"], "published-print": {"date-parts": [[2016, 5]]}, "DOI": "10.1016/j.jval.2016.03.204", "type": "journal-article", "created": {"date-parts": [[2016, 5, 23]], "date-time": "2016-05-23T15:22:17Z", "timestamp": 1464016937000}, "page": "A63", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia"], "prefix": "10.1016", "volume": "19", "author": [{"given": "J", "family": "Ordo\u00f1ez", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Delgado", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Value in Health"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1098301516002722?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1098301516002722?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 11]], "date-time": "2018-09-11T21:56:42Z", "timestamp": 1536703002000}, "score": 45.12446, "issued": {"date-parts": [[2016, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 5]]}, "issue": "3"}, "alternative-id": ["S1098301516002722"], "URL": "http://dx.doi.org/10.1016/j.jval.2016.03.204", "ISSN": ["1098-3015"], "issn-type": [{"value": "1098-3015", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:57:47Z", "timestamp": 1574708267954}, "reference-count": 34, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 130, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CPT Pharmacometrics Syst. Pharmacol."], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.1002/psp4.36", "type": "journal-article", "created": {"date-parts": [[2015, 7, 2]], "date-time": "2015-07-02T06:00:42Z", "timestamp": 1435816842000}, "page": "295-304", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis"], "prefix": "10.1002", "volume": "4", "author": [{"given": "A", "family": "Gulati", "sequence": "first", "affiliation": [{"name": "Indiana University School of Medicine; Indianapolis Indiana USA"}, {"name": "Indiana Clinical and Translational Sciences Institute (CTSI); Indianapolis Indiana USA"}]}, {"given": "F", "family": "Bagnato", "sequence": "additional", "affiliation": [{"name": "Neuroimmunology Branch; National Institute of Neurological Disorders and Stroke, National Institutes of Health; Bethesda Maryland USA"}]}, {"given": "P", "family": "Villoslada", "sequence": "additional", "affiliation": [{"name": "Center for Neuroimmunology; Institute of Biomedical Research August Pi Sunyer (IDIBAPS); Hospital Clinic of Barcelona; Barcelona Spain"}]}, {"given": "N", "family": "Velez de Mendizabal", "sequence": "additional", "affiliation": [{"name": "Indiana University School of Medicine; Indianapolis Indiana USA"}, {"name": "Indiana Clinical and Translational Sciences Institute (CTSI); Indianapolis Indiana USA"}]}], "member": "311", "published-online": {"date-parts": [[2015, 4, 24]]}, "reference": [{"key": "10.1002/psp4.36-BIB0001|psp436-cit-0002", "first-page": "175", "article-title": "Multiple sclerosis review", "volume": "37", "author": "Goldenberg", "year": "2012", "journal-title": "P. T."}, {"key": "10.1002/psp4.36-BIB0002|psp436-cit-0003", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1007/BF02786470", "article-title": "The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy", "volume": "20", "author": "Singh", "year": "1999", "journal-title": "Immunol. Res."}, {"key": "10.1002/psp4.36-BIB0003|psp436-cit-0004", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B", "article-title": "Review: cytokines and the pathogenesis of multiple sclerosis", "volume": "45", "author": "Navikas", "year": "1996", "journal-title": "J. Neurosci. Res."}, {"key": "10.1002/psp4.36-BIB0004|psp436-cit-0005", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1186/1752-0509-5-114", "article-title": "Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in multiple sclerosis", "volume": "5", "author": "V\u00e9lez de Mendiz\u00e1bal", "year": "2011", "journal-title": "BMC Syst. Biol."}, {"key": "10.1002/psp4.36-BIB0005|psp436-cit-0006", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1016/S1474-4422(09)70082-1", "article-title": "Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis", "volume": "8", "author": "Rudick", "year": "2009", "journal-title": "Lancet Neurol."}, {"key": "10.1002/psp4.36-BIB0006|psp436-cit-0007", "first-page": "1935", "article-title": "Diagnosis and management of multiple sclerosis", "volume": "70", "author": "Calabresi", "year": "2004", "journal-title": "Am. Fam. Physician"}, {"key": "10.1002/psp4.36-BIB0007|psp436-cit-0008", "doi-asserted-by": "crossref", "first-page": "548", "DOI": "10.1002/ana.410290515", "article-title": "Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history", "volume": "29", "author": "Harris", "year": "1991", "journal-title": "Ann. Neurol."}, {"key": "10.1002/psp4.36-BIB0008|psp436-cit-0009", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1046/j.1468-1331.1999.640455.x", "article-title": "Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis", "volume": "6", "author": "Ciccarelli", "year": "1999", "journal-title": "Eur. J. Neurol."}, {"key": "10.1002/psp4.36-BIB0009|psp436-cit-0010", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1002/ana.410420515", "article-title": "Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology", "volume": "42", "author": "Br\u00fcck", "year": "1997", "journal-title": "Ann. Neurol."}, {"key": "10.1002/psp4.36-BIB0010|psp436-cit-0011", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1016/S0022-510X(98)00162-2", "article-title": "Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement", "volume": "159", "author": "Filippi", "year": "1998", "journal-title": "J. Neurol. Sci"}, {"issue": "Pt 7", "key": "10.1002/psp4.36-BIB0011|psp436-cit-0012", "doi-asserted-by": "crossref", "first-page": "1463", "DOI": "10.1093/brain/awh176", "article-title": "Development of biomarkers in multiple sclerosis", "volume": "127", "author": "Bielekova", "year": "2004", "journal-title": "Brain"}, {"key": "10.1002/psp4.36-BIB0012|psp436-cit-0013", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1016/S0022-510X(99)00015-5", "article-title": "Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials", "volume": "163", "author": "Sormani", "year": "1999", "journal-title": "J. Neurol. Sci"}, {"key": "10.1002/psp4.36-BIB0013|psp436-cit-0014", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1016/j.pneurobio.2011.04.007", "article-title": "Development of biomarkers for multiple sclerosis as a neurodegenerative disorder", "volume": "95", "author": "Ziemann", "year": "2011", "journal-title": "Prog. Neurobiol"}, {"key": "10.1002/psp4.36-BIB0014|psp436-cit-0015", "doi-asserted-by": "crossref", "first-page": "e73361", "DOI": "10.1371/journal.pone.0073361", "article-title": "Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach", "volume": "8", "author": "Velez de Mendizabal", "year": "2013", "journal-title": "PLoS One"}, {"key": "10.1002/psp4.36-BIB0015|psp436-cit-0016", "doi-asserted-by": "crossref", "first-page": "1764", "DOI": "10.1056/NEJM199312093292403", "article-title": "The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group", "volume": "329", "author": "Beck", "year": "1993", "journal-title": "N. Engl. J. Med"}, {"key": "10.1002/psp4.36-BIB0016|psp436-cit-0017", "author": "Cree", "year": "2007", "volume-title": "Current Diagnosis and Treatment in Neurology"}, {"key": "10.1002/psp4.36-BIB0017|psp436-cit-0018", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1159/000117038", "article-title": "Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses", "volume": "34", "author": "La Mantia", "year": "1994", "journal-title": "Eur. Neurol"}, {"key": "10.1002/psp4.36-BIB0018|psp436-cit-0019", "doi-asserted-by": "crossref", "first-page": "1628", "DOI": "10.1212/WNL.56.12.1628", "article-title": "PRISMS-4: long-term efficacy of interferon-beta-1a in relapsing MS", "volume": "56", "author": "Prisms Study Group and the University of British Columbia MS/MRI Analysis Group", "year": "2001", "journal-title": "Neurology"}, {"key": "10.1002/psp4.36-BIB0019|psp436-cit-0020", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1212/WNL.43.4.662", "article-title": "Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group", "volume": "43", "author": "Paty", "year": "1993", "journal-title": "Neurology"}, {"issue": "Pt 8", "key": "10.1002/psp4.36-BIB0020|psp436-cit-0021", "doi-asserted-by": "crossref", "first-page": "1782", "DOI": "10.1093/brain/awg182", "article-title": "Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years", "volume": "126", "author": "Bagnato", "year": "2003", "journal-title": "Brain"}, {"key": "10.1002/psp4.36-BIB0021|psp436-cit-0022", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1111/j.1365-2249.2007.03467.x", "article-title": "A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging", "volume": "150", "author": "Chiu", "year": "2007", "journal-title": "Clin. Exp. Immunol"}, {"key": "10.1002/psp4.36-BIB0022|psp436-cit-0023", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1001/archneur.66.1.noc80047", "article-title": "Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study", "volume": "66", "author": "Chiu", "year": "2009", "journal-title": "Arch. Neurol"}, {"key": "10.1002/psp4.36-BIB0023|psp436-cit-0024", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1007/s10928-009-9126-8", "article-title": "Performance in population models for count data, part I: maximum likelihood approximations", "volume": "36", "author": "Plan", "year": "2009", "journal-title": "J. Pharmacokinet. Pharmacodyn"}, {"key": "10.1002/psp4.36-BIB0024|psp436-cit-0025", "doi-asserted-by": "crossref", "first-page": "e129", "DOI": "10.1038/psp.2014.27", "article-title": "Modeling and simulation of count data", "volume": "3", "author": "Plan", "year": "2014", "journal-title": "CPT Pharmacometrics Syst. Pharmacol"}, {"key": "10.1002/psp4.36-BIB0025|psp436-cit-0026", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1007/BF02353864", "article-title": "Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection", "volume": "22", "author": "Ludden", "year": "1994", "journal-title": "J. Pharmacokinet. Biopharm"}, {"key": "10.1002/psp4.36-BIB0026|psp436-cit-0027", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/j.cmpb.2005.04.005", "article-title": "PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM", "volume": "79", "author": "Lindbom", "year": "2005", "journal-title": "Comput. Methods Programs Biomed"}, {"key": "10.1002/psp4.36-BIB0027|psp436-cit-0028", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/j.cmpb.2003.11.003", "article-title": "Perl-speaks-NONMEM (PsN)-a Perl module for NONMEM related programming", "volume": "75", "author": "Lindbom", "year": "2004", "journal-title": "Comput. Methods Programs Biomed"}, {"key": "10.1002/psp4.36-BIB0028|psp436-cit-0029", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1111/bcp.12170", "article-title": "Clinical pharmacology\u2009=\u2009disease progression\u2009+\u2009drug action", "volume": "79", "author": "Holford", "year": "2015", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "10.1002/psp4.36-BIB0029|psp436-cit-0030", "first-page": "675", "article-title": "Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR", "volume": "19", "author": "Waesberghe", "year": "1998", "journal-title": "AJNR Am. J. Neuroradiol"}, {"key": "10.1002/psp4.36-BIB0030|psp436-cit-0031", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.17925/USN.2011.07.01.46", "article-title": "Application of interferon beta-1b in multiple sclerosis", "volume": "7", "author": "Bagnato", "year": "2011", "journal-title": "US Neurol."}, {"key": "10.1002/psp4.36-BIB0031|psp436-cit-0032", "doi-asserted-by": "crossref", "first-page": "1684", "DOI": "10.1001/archneur.62.11.noc40499", "article-title": "Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations", "volume": "62", "author": "Bagnato", "year": "2005", "journal-title": "Arch. Neurol"}, {"key": "10.1002/psp4.36-BIB0032|psp436-cit-0033", "doi-asserted-by": "crossref", "first-page": "1823", "DOI": "10.1517/14712590802510629", "article-title": "The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis", "volume": "8", "author": "Gaindh", "year": "2008", "journal-title": "Expert Opin. Biol. Ther"}, {"key": "10.1002/psp4.36-BIB0033|psp436-cit-0034", "unstructured": "US Food and Drug Administration http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/ifnbchi031403lb.pdf 2003"}, {"key": "10.1002/psp4.36-BIB0034|psp436-cit-0035", "unstructured": "European Medicines Agency http://0077ww.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000933/WC500034702.pdf 2012"}], "container-title": ["CPT: Pharmacometrics & Systems Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsp4.36", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T14:55:28Z", "timestamp": 1498229728000}, "score": 44.925537, "subtitle": ["Predicting Relapsing-Remitting Dynamics in MS"], "issued": {"date-parts": [[2015, 4, 24]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2015, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/psp4.36", "relation": {"cites": []}, "ISSN": ["2163-8306"], "issn-type": [{"value": "2163-8306", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:59:11Z", "timestamp": 1575291551381}, "reference-count": 0, "publisher": "SAGE Publications", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis"], "published-print": {"date-parts": [[2002, 4, 1]]}, "DOI": "10.1191/1352458502ms788oa", "type": "journal-article", "created": {"date-parts": [[2008, 7, 28]], "date-time": "2008-07-28T14:03:49Z", "timestamp": 1217253829000}, "page": "119-123", "source": "Crossref", "is-referenced-by-count": 29, "title": ["MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a"], "prefix": "10.1191", "volume": "8", "author": [{"given": "C", "family": "Gasperini", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Paolillo", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Giugni", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Galgani", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Bagnato", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Mainero", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Onesti", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Bastianello", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Pozzilli", "sequence": "additional", "affiliation": []}], "member": "179", "container-title": ["Multiple Sclerosis"], "language": "en", "deposited": {"date-parts": [[2011, 7, 27]], "date-time": "2011-07-27T03:40:19Z", "timestamp": 1311738019000}, "score": 44.34819, "issued": {"date-parts": [[2002, 4, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 4, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1191/1352458502ms788oa", "ISSN": ["1352-4585"], "issn-type": [{"value": "1352-4585", "type": "print"}], "subject": ["Neurology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:37:09Z", "timestamp": 1574336229239}, "reference-count": 10, "publisher": "Oxford University Press (OUP)", "issue": "2", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/4.0/", "start": {"date-parts": [[2016, 10, 2]], "date-time": "2016-10-02T00:00:00Z", "timestamp": 1475366400000}, "delay-in-days": 2511, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Kidney Journal"], "published-print": {"date-parts": [[2010, 4, 1]]}, "DOI": "10.1093/ndtplus/sfp162", "type": "journal-article", "created": {"date-parts": [[2009, 11, 18]], "date-time": "2009-11-18T03:11:09Z", "timestamp": 1258513869000}, "page": "132-134", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis"], "prefix": "10.1093", "volume": "3", "author": [{"given": "A.", "family": "Aravindan", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Yong", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Killingsworth", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Suranyi", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Wong", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2009, 11, 17]]}, "reference": [{"key": "1_46391848", "volume": "53", "first-page": "1622", "year": "1999", "journal-title": "OGPL Neurology", "DOI": "10.1212/WNL.53.8.1622", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "2_13145424", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1056/NEJM198401053100107", "volume": "310", "author": "Averbuch", "year": "1984", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "10", "key": "3_19985783", "doi-asserted-by": "publisher", "first-page": "2111", "DOI": "10.1093/ndt/16.10.2111-a", "volume": "16", "author": "Magee", "year": "2001", "journal-title": "Nephrology Dialysis Transplantation", "ISSN": "http://id.crossref.org/issn/0931-0509", "issn-type": "print"}, {"issue": "3", "key": "4_17667012", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1097/00000421-200306000-00011", "volume": "26", "author": "Bremer", "year": "2003", "journal-title": "American journal of clinical oncology : the official publication of the American Radium Society", "ISSN": "http://id.crossref.org/issn/0277-3732", "issn-type": "print"}, {"issue": "5", "key": "5_10571456", "first-page": "425", "volume": "54", "author": "Gotsman", "year": "2000", "journal-title": "Clinical nephrology", "ISSN": "http://id.crossref.org/issn/0301-0430", "issn-type": "print"}, {"issue": "6", "key": "6_17722083", "doi-asserted-by": "publisher", "first-page": "768", "DOI": "10.1007/s00415-003-1090-4", "volume": "250", "author": "Tola", "year": "2003", "journal-title": "Journal of neurology", "ISSN": "http://id.crossref.org/issn/0340-5354", "issn-type": "print"}, {"issue": "3", "key": "7_21569328", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1017/S0317167100004303", "volume": "32", "author": "Auty", "year": "2005", "journal-title": "The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques", "ISSN": "http://id.crossref.org/issn/0317-1671", "issn-type": "print"}, {"issue": "3", "key": "8_22730167", "doi-asserted-by": "publisher", "first-page": "222", "DOI": "10.1007/s10157-006-0424-9", "volume": "10", "author": "Kumasaka", "year": "2006", "journal-title": "Clinical and experimental nephrology", "ISSN": "http://id.crossref.org/issn/1342-1751", "issn-type": "print"}, {"issue": "10", "key": "9_17322408", "doi-asserted-by": "publisher", "first-page": "854", "DOI": "10.1007/s005350200141", "volume": "37", "author": "Nishimura", "year": "2002", "journal-title": "Journal of gastroenterology", "ISSN": "http://id.crossref.org/issn/0944-1174", "issn-type": "print"}, {"issue": "1", "key": "10_17344284", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1016/S0303-8467(02)00087-2", "volume": "105", "author": "Emsley", "year": "2002", "journal-title": "Clinical neurology and neurosurgery", "ISSN": "http://id.crossref.org/issn/0303-8467", "issn-type": "print"}], "container-title": ["Clinical Kidney Journal"], "language": "en", "link": [{"URL": "http://academic.oup.com/ckj/article-pdf/3/2/132/995801/sfp162.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T22:42:23Z", "timestamp": 1558651343000}, "score": 43.532326, "issued": {"date-parts": [[2009, 11, 17]]}, "references-count": 10, "journal-issue": {"published-online": {"date-parts": [[2010, 3, 25]]}, "published-print": {"date-parts": [[2010, 4, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1093/ndtplus/sfp162", "relation": {"cites": []}, "ISSN": ["2048-8505", "2048-8513"], "issn-type": [{"value": "2048-8505", "type": "print"}, {"value": "2048-8513", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T23:34:30Z", "timestamp": 1574552070255}, "reference-count": 20, "publisher": "Wiley", "issue": "10", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 335, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Intern Med J"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.1111/imj.12558", "type": "journal-article", "created": {"date-parts": [[2014, 10, 10]], "date-time": "2014-10-10T03:29:47Z", "timestamp": 1412911787000}, "page": "950-957", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Current management of relapsing-remitting multiple sclerosis"], "prefix": "10.1111", "volume": "44", "author": [{"given": "L.", "family": "Sedal", "sequence": "first", "affiliation": [{"name": "Neuroimmunology Clinic; Clinical Neurosciences; St Vincent's Hospital Melbourne; Melbourne Victoria Australia"}]}, {"given": "I. B.", "family": "Wilson", "sequence": "additional", "affiliation": [{"name": "Neuroimmunology Clinic; Clinical Neurosciences; St Vincent's Hospital Melbourne; Melbourne Victoria Australia"}]}, {"given": "E. A.", "family": "McDonald", "sequence": "additional", "affiliation": [{"name": "Neuroimmunology Clinic; Clinical Neurosciences; St Vincent's Hospital Melbourne; Melbourne Victoria Australia"}, {"name": "MS Australia; Melbourne Victoria Australia"}]}], "member": "311", "published-online": {"date-parts": [[2014, 10, 9]]}, "reference": [{"key": "10.1111/imj.12558-BIB0001|imj12558-cit-0001", "doi-asserted-by": "crossref", "first-page": "1315", "DOI": "10.1212/WNL.0b013e3182535cf6", "article-title": "Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFN\u03b2-1b trial", "volume": "78", "author": "Goodin", "year": "2012", "journal-title": "Neurology"}, {"key": "10.1111/imj.12558-BIB0002|imj12558-cit-0002", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1002/ana.23938", "article-title": "Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis", "volume": "73", "author": "Khan", "year": "2013", "journal-title": "Ann Neurol"}, {"key": "10.1111/imj.12558-BIB0003|imj12558-cit-0003", "doi-asserted-by": "crossref", "first-page": "2018", "DOI": "10.1016/S0140-6736(02)12023-X", "article-title": "Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial", "volume": "360", "author": "Hartung", "year": "2002", "journal-title": "Lancet"}, {"key": "10.1111/imj.12558-BIB0004|imj12558-cit-0004", "doi-asserted-by": "crossref", "first-page": "1870", "DOI": "10.1056/NEJMoa1107829", "article-title": "Risk of natalizumab-associated progressive multifocal leukoencephalopathy", "volume": "366", "author": "Bloomgren", "year": "2012", "journal-title": "N Engl J Med"}, {"key": "10.1111/imj.12558-BIB0005|imj12558-cit-0005", "doi-asserted-by": "crossref", "first-page": "1826", "DOI": "10.1177/1352458513510224", "article-title": "The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy", "volume": "19", "author": "Wattjes", "year": "2013", "journal-title": "Mult Scler"}, {"key": "10.1111/imj.12558-BIB0006|imj12558-cit-0006", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1056/NEJMct1101691", "article-title": "Fingolimod for multiple sclerosis", "volume": "366", "author": "Pelletier", "year": "2012", "journal-title": "N Engl J Med"}, {"key": "10.1111/imj.12558-BIB0007|imj12558-cit-0007", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1007/s00415-010-5777-z", "article-title": "BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis", "volume": "258", "author": "MacManus", "year": "2011", "journal-title": "J Neurol"}, {"issue": "Suppl 2", "key": "10.1111/imj.12558-BIB0008|imj12558-cit-0008", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1212/WNL.0b013e318277d144", "article-title": "MS, MRI, and the2010 McDonald criteria: a Canadian expert commentary", "volume": "79", "author": "Selchen", "year": "2012", "journal-title": "Neurology"}, {"key": "10.1111/imj.12558-BIB0009|imj12558-cit-0009", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/S1474-4422(11)70274-5", "article-title": "Clinically isolated syndromes", "volume": "11", "author": "Miller", "year": "2012", "journal-title": "Lancet Neurol"}, {"key": "10.1111/imj.12558-BIB0010|imj12558-cit-0010", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1016/j.ncl.2011.01.001", "article-title": "Natural history of multiple sclerosis: early prognostic factors", "volume": "29", "author": "Mowry", "year": "2011", "journal-title": "Neurol Clin"}, {"key": "10.1111/imj.12558-BIB0011|imj12558-cit-0011", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1097/WCO.0b013e328346bf66", "article-title": "Multiple sclerosis: current treatment algorithms", "volume": "24", "author": "R\u00edo", "year": "2011", "journal-title": "Curr Opin Neurol"}, {"key": "10.1111/imj.12558-BIB0012|imj12558-cit-0012", "doi-asserted-by": "crossref", "first-page": "534", "DOI": "10.1212/WNL.0b013e31820b7630", "article-title": "Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions", "volume": "76", "author": "Tallantyre", "year": "2011", "journal-title": "Neurology"}, {"key": "10.1111/imj.12558-BIB0013|imj12558-cit-0013", "doi-asserted-by": "crossref", "first-page": "926", "DOI": "10.1148/radiol.12120208", "article-title": "FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins", "volume": "265", "author": "Sati", "year": "2012", "journal-title": "Radiology"}, {"key": "10.1111/imj.12558-BIB0014|imj12558-cit-0014", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1016/j.ncl.2010.12.012", "article-title": "Treatment of multiple sclerosis exacerbations", "volume": "29", "author": "Repovic", "year": "2011", "journal-title": "Neurol Clin"}, {"key": "10.1111/imj.12558-BIB0015|imj12558-cit-0015", "doi-asserted-by": "crossref", "first-page": "926", "DOI": "10.1007/s00415-009-5441-7", "article-title": "Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management", "volume": "257", "author": "Simmons", "year": "2010", "journal-title": "J Neurol"}, {"key": "10.1111/imj.12558-BIB0016|imj12558-cit-0016", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1016/S1474-4422(05)70193-9", "article-title": "Symptomatic therapy and neurorehabilitation in multiple sclerosis", "volume": "4", "author": "Kesselring", "year": "2005", "journal-title": "Lancet Neurol"}, {"key": "10.1111/imj.12558-BIB0017|imj12558-cit-0017", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1016/S0140-6736(09)60442-6", "article-title": "Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial", "volume": "373", "author": "Goodman", "year": "2009", "journal-title": "Lancet"}, {"key": "10.1111/imj.12558-BIB0018|imj12558-cit-0018", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1212/WNL.0000000000000250", "article-title": "Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology", "volume": "82", "author": "Yadav", "year": "2014", "journal-title": "Neurology"}, {"key": "10.1111/imj.12558-BIB0019|imj12558-cit-0019", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1212/WNL.0b013e31825dcdd9", "article-title": "A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor", "volume": "79", "author": "Van Der Walt", "year": "2012", "journal-title": "Neurology"}, {"key": "10.1111/imj.12558-BIB0020|imj12558-cit-0020", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1186/2047-9158-1-20", "article-title": "Post subthalamic area deep brain stimulation for tremors: a mini-review", "volume": "1", "author": "Xie", "year": "2012", "journal-title": "Transl Neurodegener"}], "container-title": ["Internal Medicine Journal"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fimj.12558", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 16]], "date-time": "2019-08-16T02:25:45Z", "timestamp": 1565922345000}, "score": 42.98324, "subtitle": ["Relapsing-remitting multiple sclerosis"], "issued": {"date-parts": [[2014, 10]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2014, 10]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1111/imj.12558", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1444-0903"], "issn-type": [{"value": "1444-0903", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:44:19Z", "timestamp": 1574117059997}, "reference-count": 27, "publisher": "SAGE Publications", "issue": "2", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2004, 4, 1]], "date-time": "2004-04-01T00:00:00Z", "timestamp": 1080777600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2004, 4]]}, "DOI": "10.1191/1352458504ms1004oa", "type": "journal-article", "created": {"date-parts": [[2004, 4, 6]], "date-time": "2004-04-06T23:24:43Z", "timestamp": 1081293883000}, "page": "126-138", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Longitudinal analyses of the effects of neutralizing antibodies on interferon                 beta-1b in relapsing-remitting multiple sclerosis"], "prefix": "10.1177", "volume": "10", "author": [{"given": "A John", "family": "Petkau", "sequence": "first", "affiliation": [{"name": "Department of Statistics, University of British Columbia, 333-6356                         Agricultural Road, Vancouver, British Columbia, Canada V6T 1Z2,"}]}, {"given": "Richard A", "family": "White", "sequence": "additional", "affiliation": [{"name": "Department of Statistics, University of British Columbia, 333-6356                         Agricultural Road, Vancouver, British Columbia, Canada V6T 1Z2"}]}, {"given": "George C", "family": "Ebers", "sequence": "additional", "affiliation": [{"name": "Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road,                         Oxford OX2 6HE, UK"}]}, {"given": "Anthony T", "family": "Reder", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, MC 2030, University of Chicago, 5841 South                         Maryland Ave, Chicago, IL 60637-1470, USA"}]}, {"given": "William A", "family": "Sibley", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, University of Arizona, 1501 North Campbell, PO                         Box 245094, Tucson, AZ 85705, USA"}]}, {"given": "Fred D", "family": "Lublin", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, Mount Sinai School of Medicine, One Gustave L                         Levy Place, Annenberg 14-94, Box 1137, New York, NY 10029-6574, USA"}]}, {"given": "Donald W", "family": "Paty", "sequence": "additional", "affiliation": [{"name": "Division of Neurology, Department of Medicine, University of British                         Columbia, S195, 2211 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 2B5"}]}, {"name": "IFNB Multiple Sclerosis Study Group", "sequence": "additional", "affiliation": []}], "member": "179", "published-online": {"date-parts": [[2016, 7, 2]]}, "reference": [{"key": "atypb1", "author": "IFNB Multiple Sclerosis Study Group", "volume": "47", "first-page": "889", "year": "1996", "journal-title": "Neurology", "DOI": "10.1212/WNL.47.4.889", "doi-asserted-by": "crossref"}, {"key": "atypb2", "author": "Files JG", "volume": "18", "first-page": "1019", "year": "1998", "journal-title": "J Interferon Cytokine Res", "DOI": "10.1089/jir.1998.18.1019", "doi-asserted-by": "crossref"}, {"key": "atypb3", "author": "Pungor E", "volume": "18", "first-page": "1025", "year": "1998", "journal-title": "J Interferon Cytokine Res", "DOI": "10.1089/jir.1998.18.1025", "doi-asserted-by": "crossref"}, {"key": "atypb4", "author": "Arnason BG", "volume": "18", "first-page": "639", "year": "1998", "journal-title": "J Interferon Cytokine Res", "DOI": "10.1089/jir.1998.18.639", "doi-asserted-by": "crossref"}, {"key": "atypb5", "author": "Liang KY", "volume": "73", "first-page": "13", "year": "1986", "journal-title": "Biometrika", "DOI": "10.1093/biomet/73.1.13", "doi-asserted-by": "crossref"}, {"key": "atypb6", "author": "Zeger SL", "volume": "42", "first-page": "121", "year": "1986", "journal-title": "Biometrics", "DOI": "10.2307/2531248", "doi-asserted-by": "crossref"}, {"key": "atypb7", "author": "Zeger SL", "volume": "11", "first-page": "1825", "year": "1992", "journal-title": "Statist Med", "DOI": "10.1002/sim.4780111406", "doi-asserted-by": "crossref"}, {"key": "atypb8", "author": "Liang KY", "volume": "14", "first-page": "43", "year": "1993", "journal-title": "Annu Rev Pub Health", "DOI": "10.1146/annurev.pu.14.050193.000355", "doi-asserted-by": "crossref"}, {"key": "atypb9", "author": "Rudick RA", "volume": "50", "first-page": "1266", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.50.5.1266", "doi-asserted-by": "crossref"}, {"key": "atypb10", "author": "IFNB Multiple Sclerosis Study Group", "volume": "43", "first-page": "655", "year": "1993", "journal-title": "Neurology", "DOI": "10.1212/WNL.43.4.655", "doi-asserted-by": "crossref"}, {"key": "atypb11", "author": "Paty DW", "volume": "43", "first-page": "662", "year": "1993", "journal-title": "Neurology", "DOI": "10.1212/WNL.43.4.662", "doi-asserted-by": "crossref"}, {"key": "atypb12", "author": "IFNB Multiple Sclerosis Study Group", "volume": "45", "first-page": "1277", "year": "1995", "journal-title": "Neurology", "DOI": "10.1212/WNL.45.7.1277", "doi-asserted-by": "crossref"}, {"key": "atypb13", "author": "Jacobs LD", "volume": "39", "first-page": "285", "year": "1996", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410390304", "doi-asserted-by": "crossref"}, {"key": "atypb14", "author": "PRISMS (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group", "volume": "352", "first-page": "1498", "year": "1998", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(98)03334-0", "doi-asserted-by": "crossref"}, {"key": "atypb15", "author": "European Study Group on Interferon b-1b in Secondary Progressive Multiple Sclerosis", "volume": "352", "first-page": "1491", "year": "1998", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(98)10039-9", "doi-asserted-by": "crossref"}, {"key": "atypb16", "author": "Goodkin DE", "volume": "54", "first-page": "2352", "year": "2000", "journal-title": "Neurology", "DOI": "10.1212/WNL.54.7.1414", "doi-asserted-by": "crossref"}, {"key": "atypb17", "author": "McFarland HF.", "volume": "54", "first-page": "2352", "year": "2000", "journal-title": "Neurology"}, {"key": "atypb18", "author": "SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon b-1a in Multiple Sclerosis) Study Group", "volume": "56", "first-page": "1496", "year": "2001", "journal-title": "Neurology", "DOI": "10.1212/WNL.56.11.1496", "doi-asserted-by": "crossref"}, {"key": "atypb19", "author": "Calabresi PA", "volume": "48", "first-page": "A80", "year": "1997", "journal-title": "Neurology", "DOI": "10.1212/WNL.48.5.1446", "doi-asserted-by": "crossref"}, {"key": "atypb20", "author": "Oger JJF", "volume": "48", "first-page": "A80", "year": "1997", "journal-title": "Neurology"}, {"key": "atypb21", "author": "Antonelli G", "volume": "18", "first-page": "345", "year": "1998", "journal-title": "J Interferon Cytokine Res", "DOI": "10.1089/jir.1998.18.345", "doi-asserted-by": "crossref"}, {"key": "atypb22", "author": "Zipp F", "volume": "43", "first-page": "116", "year": "1998", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410430120", "doi-asserted-by": "crossref"}, {"key": "atypb23", "author": "Diggle PJ", "year": "2002", "volume-title": "Analysis of long-itudinal data"}, {"key": "atypb24", "author": "Oberg K", "first-page": "509", "year": "1997", "volume-title": "Interferon therapy of multiple sclerosis"}, {"key": "atypb25", "author": "Leroy V", "volume": "28", "first-page": "375", "year": "1998", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(98)80309-7", "doi-asserted-by": "crossref"}, {"key": "atypb26", "author": "Hoffmann RM", "volume": "37", "first-page": "715", "year": "1999", "journal-title": "Z Gastroenterol"}, {"key": "atypb27", "author": "Rice GPA", "volume": "52", "first-page": "1277", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.6.1277", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458504ms1004oa", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458504ms1004oa", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T07:53:25Z", "timestamp": 1556783605000}, "score": 42.331512, "issued": {"date-parts": [[2004, 4]]}, "references-count": 27, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 2]]}, "published-print": {"date-parts": [[2004, 4]]}, "issue": "2"}, "alternative-id": ["10.1191/1352458504ms1004oa"], "URL": "http://dx.doi.org/10.1191/1352458504ms1004oa", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:37:21Z", "timestamp": 1574131041321}, "reference-count": 12, "publisher": "SAGE Publications", "issue": "1", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2002, 2, 1]], "date-time": "2002-02-01T00:00:00Z", "timestamp": 1012521600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2002, 2]]}, "DOI": "10.1191/1352458502ms771sr", "type": "journal-article", "created": {"date-parts": [[2002, 7, 27]], "date-time": "2002-07-27T12:37:23Z", "timestamp": 1027773443000}, "page": "15-18", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Both paracetamol and ibuprofen are equally effective in managing flu-like                 symptoms in relapsing-remitting multiple sclerosis patients during interferon                 beta-1a (AVONEX\u00ae) therapy"], "prefix": "10.1177", "volume": "8", "author": [{"given": "J", "family": "Ree\u00df", "sequence": "first", "affiliation": [{"name": "Clinic for Neurology Dietenbronn, 88477 Schwendi, Germany"}]}, {"given": "J", "family": "Haas", "sequence": "additional", "affiliation": [{"name": "Clinic for Neurology, Jewish Hospital, 13347 Berlin, Germany"}]}, {"given": "K", "family": "Gabriel", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}, {"given": "A", "family": "Fuhlrott", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}, {"given": "M", "family": "Fiola", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}], "member": "179", "published-online": {"date-parts": [[2016, 7, 2]]}, "reference": [{"key": "atypb1", "author": "Jacobs LD", "volume": "39", "first-page": "285", "year": "1996", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410390304", "doi-asserted-by": "crossref"}, {"key": "atypb2", "author": "Walther EU", "volume": "53", "first-page": "1622", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.53.8.1622", "doi-asserted-by": "crossref"}, {"key": "atypb3", "author": "Herndon RM", "volume": "1", "first-page": "1", "year": "1999", "journal-title": "Int J MS Care", "DOI": "10.7224/1537-2073-1.2.1", "doi-asserted-by": "crossref"}, {"key": "atypb4", "author": "Munschauer FE", "volume": "19", "first-page": "883", "year": "1997", "journal-title": "Clin Ther", "DOI": "10.1016/S0149-2918(97)80042-2", "doi-asserted-by": "crossref"}, {"key": "atypb5", "author": "Lublin FD", "volume": "46", "first-page": "12", "year": "1996", "journal-title": "Neurology", "DOI": "10.1212/WNL.46.1.12", "doi-asserted-by": "crossref"}, {"key": "atypb6", "author": "Bayas A", "volume": "22", "first-page": "149", "year": "2000", "journal-title": "Drug Saf", "DOI": "10.2165/00002018-200022020-00006", "doi-asserted-by": "crossref"}, {"key": "atypb7", "author": "Rice GPA", "volume": "52", "first-page": "1893", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.9.1893", "doi-asserted-by": "crossref"}, {"key": "atypb8", "author": "Mohr DC", "volume": "4", "first-page": "487", "year": "1998", "journal-title": "Mult Scler"}, {"key": "atypb9", "author": "Rieckmann P", "volume": "64", "first-page": "193", "year": "1996", "journal-title": "J Neuroimmunol", "DOI": "10.1016/0165-5728(95)00176-X", "doi-asserted-by": "crossref"}, {"key": "atypb10", "author": "Weber F", "volume": "44", "first-page": "27", "year": "1998", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410440109", "doi-asserted-by": "crossref"}, {"key": "atypb11", "author": "R\u00f3o J", "volume": "50", "first-page": "1910", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.50.6.1910", "doi-asserted-by": "crossref"}, {"key": "atypb12", "author": "Sellebjerg F", "volume": "51", "first-page": "529", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.51.2.529", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458502ms771sr", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1191/1352458502ms771sr", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T07:58:20Z", "timestamp": 1556783900000}, "score": 42.2309, "issued": {"date-parts": [[2002, 2]]}, "references-count": 12, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 2]]}, "published-print": {"date-parts": [[2002, 2]]}, "issue": "1"}, "alternative-id": ["10.1191/1352458502ms771sr"], "URL": "http://dx.doi.org/10.1191/1352458502ms771sr", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:02:04Z", "timestamp": 1574283724894}, "reference-count": 12, "publisher": "SAGE Publications", "issue": "1_suppl", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2002, 9, 1]], "date-time": "2002-09-01T00:00:00Z", "timestamp": 1030838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2002, 9]]}, "DOI": "10.1177/135245850200800104", "type": "journal-article", "created": {"date-parts": [[2009, 3, 5]], "date-time": "2009-03-05T01:33:53Z", "timestamp": 1236216833000}, "page": "15-18", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-la (AVONEX\u00ae) therapy"], "prefix": "10.1177", "volume": "8", "author": [{"given": "J.", "family": "Ree\u00df", "sequence": "first", "affiliation": [{"name": "Clinic for Neurology Dietenbronn, 88477 Schwendi, Germany"}]}, {"given": "J.", "family": "Haas", "sequence": "additional", "affiliation": [{"name": "Clinic for Neurology, Jewish Hospital, 13347 Berlin,\rGermany"}]}, {"given": "K.", "family": "Gabriel", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}, {"given": "A.", "family": "Fuhlrott", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}, {"given": "M.", "family": "Fiola", "sequence": "additional", "affiliation": [{"name": "Biogen GmbH, 85737 Ismaning, Germany"}]}], "member": "179", "published-online": {"date-parts": [[2017, 11, 13]]}, "reference": [{"key": "atypb1", "volume": "39", "first-page": "285", "year": "1996", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410390304", "doi-asserted-by": "crossref"}, {"key": "atypb2", "volume": "53", "first-page": "1622", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.53.8.1622", "doi-asserted-by": "crossref"}, {"key": "atypb3", "volume": "1", "first-page": "1", "year": "1999", "journal-title": "Int J MS Care", "DOI": "10.7224/1537-2073-1.2.1", "doi-asserted-by": "crossref"}, {"key": "atypb4", "volume": "19", "first-page": "883", "year": "1997", "journal-title": "Clin Ther", "DOI": "10.1016/S0149-2918(97)80042-2", "doi-asserted-by": "crossref"}, {"key": "atypb5", "volume": "46", "first-page": "12", "year": "1996", "journal-title": "Neurology", "DOI": "10.1212/WNL.46.1.12", "doi-asserted-by": "crossref"}, {"key": "atypb6", "volume": "22", "first-page": "149", "year": "2000", "journal-title": "Drug Saf", "DOI": "10.2165/00002018-200022020-00006", "doi-asserted-by": "crossref"}, {"key": "atypb7", "volume": "52", "first-page": "1893", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.9.1893", "doi-asserted-by": "crossref"}, {"key": "atypb8", "DOI": "10.1177/135245859800400605", "doi-asserted-by": "publisher"}, {"key": "atypb9", "volume": "64", "first-page": "193", "year": "1996", "journal-title": "J Neuroimmunol", "DOI": "10.1016/0165-5728(95)00176-X", "doi-asserted-by": "crossref"}, {"key": "atypb10", "volume": "44", "first-page": "27", "year": "1998", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410440109", "doi-asserted-by": "crossref"}, {"key": "atypb11", "volume": "50", "first-page": "1910", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.50.6.1910", "doi-asserted-by": "crossref"}, {"key": "atypb12", "volume": "51", "first-page": "529", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.51.2.529", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/135245850200800104", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/135245850200800104", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T07:57:07Z", "timestamp": 1556783827000}, "score": 42.2309, "issued": {"date-parts": [[2002, 9]]}, "references-count": 12, "journal-issue": {"published-online": {"date-parts": [[2017, 11, 13]]}, "published-print": {"date-parts": [[2002, 9]]}, "issue": "1_suppl"}, "alternative-id": ["10.1177/135245850200800104"], "URL": "http://dx.doi.org/10.1177/135245850200800104", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:54:34Z", "timestamp": 1574513674857}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAMA Neurol"], "published-print": {"date-parts": [[2013, 2, 1]]}, "DOI": "10.1001/jamaneurol.2013.1017", "type": "journal-article", "created": {"date-parts": [[2012, 11, 6]], "date-time": "2012-11-06T00:03:26Z", "timestamp": 1352160206000}, "page": "248", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis"], "prefix": "10.1001", "volume": "70", "author": [{"given": "Benjamin M.", "family": "Greenberg", "sequence": "first", "affiliation": []}, {"given": "Laura", "family": "Balcer", "sequence": "additional", "affiliation": []}, {"given": "Peter A.", "family": "Calabresi", "sequence": "additional", "affiliation": []}, {"given": "Bruce", "family": "Cree", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "Cross", "sequence": "additional", "affiliation": []}, {"given": "Teresa", "family": "Frohman", "sequence": "additional", "affiliation": []}, {"given": "Ralf", "family": "Gold", "sequence": "additional", "affiliation": []}, {"given": "Eva", "family": "Havrdova", "sequence": "additional", "affiliation": []}, {"given": "Bernhard", "family": "Hemmer", "sequence": "additional", "affiliation": []}, {"given": "Bernd C.", "family": "Kieseier", "sequence": "additional", "affiliation": []}, {"given": "Robert", "family": "Lisak", "sequence": "additional", "affiliation": []}, {"given": "Aaron", "family": "Miller", "sequence": "additional", "affiliation": []}, {"given": "Michael K.", "family": "Racke", "sequence": "additional", "affiliation": []}, {"given": "Lawrence", "family": "Steinman", "sequence": "additional", "affiliation": []}, {"given": "Olaf", "family": "Stuve", "sequence": "additional", "affiliation": []}, {"given": "Heinz", "family": "Wiendl", "sequence": "additional", "affiliation": []}, {"given": "Elliot", "family": "Frohman", "sequence": "additional", "affiliation": []}], "member": "10", "container-title": ["JAMA Neurology"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamaneurology/fullarticle/1389384", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T03:44:33Z", "timestamp": 1481946273000}, "score": 42.008095, "issued": {"date-parts": [[2013, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1001/jamaneurol.2013.1017", "ISSN": ["2168-6149"], "issn-type": [{"value": "2168-6149", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:49:54Z", "timestamp": 1574178594228}, "reference-count": 30, "publisher": "Springer Science and Business Media LLC", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs"], "published-print": {"date-parts": [[2005]]}, "DOI": "10.2165/00003495-200565090-00010", "type": "journal-article", "created": {"date-parts": [[2006, 1, 21]], "date-time": "2006-01-21T10:34:10Z", "timestamp": 1137839650000}, "page": "1295-1312", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Subcutaneous Recombinant Interferon-??-1a (Rebif??)"], "prefix": "10.1007", "volume": "65", "author": [{"given": "David", "family": "Murdoch", "sequence": "first", "affiliation": []}, {"given": "Katherine A", "family": "Lyseng-Williamson", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "2", "key": "R3-10", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1212/WNL.58.2.169", "volume": "58", "author": "Goodin", "year": "2002", "journal-title": "Neurology"}, {"issue": "1", "key": "R4-10", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1007/s11940-003-0021-0", "volume": "5", "author": "Corboy", "year": "2003", "journal-title": "Curr Treat Options Neurol"}, {"key": "R6-10", "author": "Polman", "volume": "321", "first-page": "490", "year": "2000", "journal-title": "BMJ", "DOI": "10.1136/bmj.321.7259.490", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "R8-10", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1191/1352458502ms769oa", "volume": "8", "author": "Freedman", "year": "2002", "journal-title": "Mult Scler"}, {"issue": "12", "key": "R14-10", "doi-asserted-by": "crossref", "first-page": "1998", "DOI": "10.1016/S0149-2918(02)80094-7", "volume": "24", "author": "Zhang", "year": "2002", "journal-title": "Clin Ther"}, {"issue": "1", "key": "R16-10", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/S0165-5728(99)00029-6", "volume": "99", "author": "Rothuizen", "year": "1999", "journal-title": "J Neuroimmunol"}, {"issue": "10", "key": "R18-10", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1089/jir.1996.16.759", "volume": "16", "author": "Salmon", "year": "1996", "journal-title": "J Interferon Cytokine Res"}, {"issue": "2", "key": "R19-10", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1046/j.1468-1331.1998.520187.x", "volume": "5", "author": "Munafo", "year": "1998", "journal-title": "Eur J Neurol"}, {"issue": "10", "key": "R20-10", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1089/10799900050163226", "volume": "20", "author": "Buchwalder", "year": "2000", "journal-title": "J Interferon Cytokine Res"}, {"issue": "1-2", "key": "R21-10", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/S0022-1759(01)00434-3", "volume": "256", "author": "Bertolotto", "year": "2001", "journal-title": "J Immunol Methods"}, {"issue": "11", "key": "R22-10", "doi-asserted-by": "crossref", "first-page": "2055", "DOI": "10.1212/WNL.54.11.2055", "volume": "54", "author": "Deisenhammer", "year": "2000", "journal-title": "Neurology"}, {"issue": "4", "key": "R23-10", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1002/ana.1218", "volume": "50", "author": "Galboiz", "year": "2001", "journal-title": "Ann Neurol"}, {"key": "R25-10", "author": "Wandinger", "volume": "361", "first-page": "2036", "year": "2003", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(03)13641-0", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "R26-10", "doi-asserted-by": "crossref", "first-page": "1115", "DOI": "10.1001/archneur.59.7.1115", "volume": "59", "author": "Sharief", "year": "2002", "journal-title": "Arch Neurol"}, {"issue": "12", "key": "R27-10", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1089/jir.2004.24.711", "volume": "24", "author": "Harzheim", "year": "2004", "journal-title": "J Interferon Cytokine Res"}, {"issue": "3", "key": "R28-10", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1191/1352458502ms794oa", "volume": "8", "author": "Hong", "year": "2002", "journal-title": "Mult Scler"}, {"issue": "8", "key": "R29-10", "doi-asserted-by": "crossref", "first-page": "1297", "DOI": "10.1001/archneur.58.8.1297", "volume": "58", "author": "Rice", "year": "2001", "journal-title": "Arch Neurol"}, {"issue": "4", "key": "R30-10", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1212/01.WNL.0000046662.03894.C5", "volume": "60", "author": "Bertolotto", "year": "2003", "journal-title": "Neurology"}, {"issue": "5", "key": "R31-10", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.0.CO;2-V", "volume": "48", "author": "Ross", "year": "2000", "journal-title": "Ann Neurol"}, {"issue": "1", "key": "R33-10", "first-page": "56", "volume": "12", "author": "Perini", "year": "2001", "journal-title": "Eur Cytokine Netw"}, {"issue": "10", "key": "R35-10", "doi-asserted-by": "crossref", "first-page": "1496", "DOI": "10.1212/01.WNL.0000034080.43681.DA", "volume": "59", "author": "Panitch", "year": "2002", "journal-title": "Neurology"}, {"issue": "5", "key": "R38-10", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1001/archneur.62.5.785", "volume": "62", "author": "Schwid", "year": "2005", "journal-title": "Arch Neurol"}, {"issue": "9391", "key": "R40-10", "doi-asserted-by": "crossref", "first-page": "1184", "DOI": "10.1016/S0140-6736(03)14541-2", "volume": "362", "author": "Sorensen", "year": "2003", "journal-title": "Lancet"}, {"issue": "2", "key": "R42-10", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P", "volume": "46", "author": "Li", "year": "1999", "journal-title": "Ann Neurol"}, {"issue": "3", "key": "R44-10", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1191/1352458504ms1007oa", "volume": "10", "author": "Tremlett", "year": "2004", "journal-title": "Mult Scler"}, {"issue": "4", "key": "R45-10", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1212/WNL.62.4.628", "volume": "62", "author": "Tremlett", "year": "2004", "journal-title": "Neurology"}, {"issue": "11", "key": "R46-10", "doi-asserted-by": "crossref", "first-page": "1297", "DOI": "10.1007/s00415-004-0619-5", "volume": "251", "author": "Tremlett", "year": "2004", "journal-title": "J Neurol"}, {"issue": "4", "key": "R48-10", "first-page": "243", "volume": "7", "author": "Patten", "year": "2001", "journal-title": "Mult Scler"}, {"issue": "1", "key": "R49-10", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1007/s00415-005-0589-2", "volume": "252", "author": "Sandberg-Wollheim", "year": "2005", "journal-title": "J Neurol"}, {"issue": "19", "key": "R53-10", "doi-asserted-by": "crossref", "first-page": "2161", "DOI": "10.1001/archinte.162.19.2161", "volume": "162", "author": "Galetta", "year": "2002", "journal-title": "Arch Intern Med"}], "container-title": ["Drugs"], "language": "en", "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T15:19:24Z", "timestamp": 1553181564000}, "score": 41.971546, "subtitle": ["A Review of its Use in Relapsing-Remitting Multiple Sclerosis"], "issued": {"date-parts": [[2005]]}, "references-count": 30, "journal-issue": {"issue": "9"}, "URL": "http://dx.doi.org/10.2165/00003495-200565090-00010", "relation": {"cites": []}, "ISSN": ["0012-6667"], "issn-type": [{"value": "0012-6667", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T23:14:26Z", "timestamp": 1575414866582}, "reference-count": 33, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 622, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100000024", "name": "Canadian Institutes of Health Research", "doi-asserted-by": "publisher", "award": ["MOP- 93646"]}, {"DOI": "10.13039/100000890", "name": "National Multiple Sclerosis Society", "doi-asserted-by": "publisher", "award": ["RG 4202-A-2"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Eur J Neurol"], "published-print": {"date-parts": [[2014, 6]]}, "DOI": "10.1111/ene.12324", "type": "journal-article", "created": {"date-parts": [[2013, 12, 19]], "date-time": "2013-12-19T05:39:09Z", "timestamp": 1387431549000}, "page": "835-844", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study"], "prefix": "10.1111", "volume": "21", "author": [{"given": "A.", "family": "Shirani", "sequence": "first", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}, {"given": "Y.", "family": "Zhao", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology; MS/MRI Research Group; University of British Columbia; Vancouver BC Canada"}]}, {"given": "M. E.", "family": "Karim", "sequence": "additional", "affiliation": [{"name": "Department of Statistics; University of British Columbia; Vancouver BC Canada"}]}, {"given": "J.", "family": "Petkau", "sequence": "additional", "affiliation": [{"name": "Department of Statistics; University of British Columbia; Vancouver BC Canada"}]}, {"given": "P.", "family": "Gustafson", "sequence": "additional", "affiliation": [{"name": "Department of Statistics; University of British Columbia; Vancouver BC Canada"}]}, {"given": "C.", "family": "Evans", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}, {"given": "E.", "family": "Kingwell", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}, {"given": "M. L.", "family": "van der Kop", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}, {"given": "J.", "family": "Oger", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}, {"given": "H.", "family": "Tremlett", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Division of Neurology and Brain Research Centre; University of British Columbia; Vancouver BC Canada"}]}], "member": "311", "published-online": {"date-parts": [[2013, 12, 18]]}, "reference": [{"key": "10.1111/ene.12324-BIB0001|ene12324-cit-0001", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1002/ana.21640", "article-title": "The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?", "volume": "65", "author": "Weiner", "year": "2009", "journal-title": "Ann Neurol"}, {"key": "10.1111/ene.12324-BIB0002|ene12324-cit-0002", "first-page": "932351", "article-title": "Heterogeneity in multiple sclerosis: scratching the surface of a complex disease", "volume": "2011", "author": "Disanto", "year": "2010", "journal-title": "Autoimmune Dis"}, {"key": "10.1111/ene.12324-BIB0003|ene12324-cit-0003", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1001/archneurol.2008.47", "article-title": "Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis", "volume": "65", "author": "Byun", "year": "2008", "journal-title": "Arch Neurol"}, {"key": "10.1111/ene.12324-BIB0004|ene12324-cit-0004", "doi-asserted-by": "crossref", "first-page": "707", "DOI": "10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q", "article-title": "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination", "volume": "47", "author": "Lucchinetti", "year": "2000", "journal-title": "Ann Neurol"}, {"key": "10.1111/ene.12324-BIB0005|ene12324-cit-0005", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1001/archneur.66.1.noc80047", "article-title": "Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study", "volume": "66", "author": "Chiu", "year": "2009", "journal-title": "Arch Neurol"}, {"key": "10.1111/ene.12324-BIB0006|ene12324-cit-0006", "doi-asserted-by": "crossref", "first-page": "2004", "DOI": "10.1212/WNL.0b013e3181e3973f", "article-title": "New perspectives in the natural history of multiple sclerosis", "volume": "74", "author": "Tremlett", "year": "2010", "journal-title": "Neurology"}, {"key": "10.1111/ene.12324-BIB0007|ene12324-cit-0007", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1016/S0140-6736(03)12512-3", "article-title": "Interferons in relapsing remitting multiple sclerosis: a systematic review", "volume": "361", "author": "Filippini", "year": "2003", "journal-title": "Lancet"}, {"key": "10.1111/ene.12324-BIB0008|ene12324-cit-0008", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1002/ana.410390304", "article-title": "Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)", "volume": "39", "author": "Jacobs", "year": "1996", "journal-title": "Ann Neurol"}, {"key": "10.1111/ene.12324-BIB0009|ene12324-cit-0009", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1016/S0140-6736(98)03334-0", "article-title": "Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis", "volume": "352", "author": "PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group", "year": "1998", "journal-title": "Lancet"}, {"key": "10.1111/ene.12324-BIB0010|ene12324-cit-0010", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1001/archneur.55.12.1578", "article-title": "Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease?", "volume": "55", "author": "Rice", "year": "1998", "journal-title": "Arch Neurol"}, {"key": "10.1111/ene.12324-BIB0011|ene12324-cit-0011", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1136/jnnp.68.4.450", "article-title": "Disability outcome measures in therapeutic trials of relapsing\u2212remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts", "volume": "68", "author": "Liu", "year": "2000", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "10.1111/ene.12324-BIB0012|ene12324-cit-0012", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1001/jama.2012.7625", "article-title": "Association between use of interferon beta and progression of disability in patients with relapsing\u2212remitting multiple sclerosis", "volume": "308", "author": "Shirani", "year": "2012", "journal-title": "JAMA"}, {"key": "10.1111/ene.12324-BIB0013|ene12324-cit-0013", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1056/NEJMp068070", "article-title": "The challenge of subgroup analyses - reporting without distorting", "volume": "354", "author": "Lagakos", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "10.1111/ene.12324-BIB0014|ene12324-cit-0014", "doi-asserted-by": "crossref", "first-page": "1064", "DOI": "10.1016/S0140-6736(00)02039-0", "article-title": "Subgroup analysis and other (mis)uses of baseline data in clinical trials", "volume": "355", "author": "Assmann", "year": "2000", "journal-title": "Lancet"}, {"key": "10.1111/ene.12324-BIB0015|ene12324-cit-0015", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1016/S0140-6736(05)17709-5", "article-title": "Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation", "volume": "365", "author": "Rothwell", "year": "2005", "journal-title": "Lancet"}, {"key": "10.1111/ene.12324-BIB0016|ene12324-cit-0016", "doi-asserted-by": "crossref", "first-page": "2189", "DOI": "10.1056/NEJMsr077003", "article-title": "Statistics in medicine - reporting of subgroup analyses in clinical trials", "volume": "357", "author": "Wang", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1111/ene.12324-BIB0017|ene12324-cit-0017", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1136/bmj.39265.596262.AD", "article-title": "Subgroup analyses: how to avoid being misled", "volume": "335", "author": "Fletcher", "year": "2007", "journal-title": "BMJ"}, {"key": "10.1111/ene.12324-BIB0018|ene12324-cit-0018", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1186/1745-6215-10-101", "article-title": "Subgroup Analysis of Trials is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials", "volume": "10", "author": "Sun", "year": "2009", "journal-title": "Trials"}, {"key": "10.1111/ene.12324-BIB0019|ene12324-cit-0019", "doi-asserted-by": "crossref", "first-page": "e297", "DOI": "10.1371/journal.pmed.0040297", "article-title": "Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration", "volume": "4", "author": "Vandenbroucke", "year": "2007", "journal-title": "PLoS Med"}, {"key": "10.1111/ene.12324-BIB0020|ene12324-cit-0020", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1212/WNL.33.11.1444", "article-title": "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", "volume": "33", "author": "Kurtzke", "year": "1983", "journal-title": "Neurology"}, {"key": "10.1111/ene.12324-BIB0021|ene12324-cit-0021", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1002/pds.1357", "article-title": "Immortal time bias in observational studies of drug effects", "volume": "16", "author": "Suissa", "year": "2007", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "10.1111/ene.12324-BIB0022|ene12324-cit-0022", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1097/EDE.0b013e318212640c", "article-title": "Nonexperimental comparative effectiveness research using linked healthcare databases", "volume": "22", "author": "Sturmer", "year": "2011", "journal-title": "Epidemiology"}, {"key": "10.1111/ene.12324-BIB0023|ene12324-cit-0023", "first-page": "515", "article-title": "How to work with a subgroup analysis", "volume": "52", "author": "Dijkman", "year": "2009", "journal-title": "Can J Surg"}, {"key": "10.1111/ene.12324-BIB0024|ene12324-cit-0024", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/j.bbadis.2010.07.007", "article-title": "Inflammation, demyelination, and degeneration \u2212 recent insights from MS pathology", "volume": "1812", "author": "Stadelmann", "year": "2011", "journal-title": "Biochim Biophys Acta"}, {"key": "10.1111/ene.12324-BIB0025|ene12324-cit-0025", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1093/brain/awg081", "article-title": "Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process", "volume": "126", "author": "Confavreux", "year": "2003", "journal-title": "Brain"}, {"key": "10.1111/ene.12324-BIB0026|ene12324-cit-0026", "doi-asserted-by": "crossref", "first-page": "1616", "DOI": "10.1212/WNL.0b013e3181c1e44f", "article-title": "Impact of multiple sclerosis relapses on progression diminishes with time", "volume": "73", "author": "Tremlett", "year": "2009", "journal-title": "Neurology"}, {"key": "10.1111/ene.12324-BIB0027|ene12324-cit-0027", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1093/brain/awq118", "article-title": "The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability", "volume": "133", "author": "Scalfari", "year": "2010", "journal-title": "Brain"}, {"key": "10.1111/ene.12324-BIB0028|ene12324-cit-0028", "doi-asserted-by": "crossref", "first-page": "1430", "DOI": "10.1056/NEJM200011163432001", "article-title": "Relapses and progression of disability in multiple sclerosis", "volume": "343", "author": "Confavreux", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1111/ene.12324-BIB0029|ene12324-cit-0029", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1093/brain/awh721", "article-title": "The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease", "volume": "129", "author": "Kremenchutzky", "year": "2006", "journal-title": "Brain"}, {"key": "10.1111/ene.12324-BIB0030|ene12324-cit-0030", "doi-asserted-by": "crossref", "first-page": "1368", "DOI": "10.1136/jnnp.2008.145805", "article-title": "Relapses in multiple sclerosis are age- and time-dependent", "volume": "79", "author": "Tremlett", "year": "2008", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "10.1111/ene.12324-BIB0031|ene12324-cit-0031", "doi-asserted-by": "crossref", "first-page": "1414", "DOI": "10.1177/1352458510379246", "article-title": "Assessing changes in relapse rates in multiple sclerosis", "volume": "16", "author": "Inusah", "year": "2010", "journal-title": "Mult Scler"}, {"key": "10.1111/ene.12324-BIB0032|ene12324-cit-0032", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1177/1352458511422097", "article-title": "Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975\u22122009)", "volume": "18", "author": "Shirani", "year": "2012", "journal-title": "Mult Scler"}, {"key": "10.1111/ene.12324-BIB0033|ene12324-cit-0033", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1177/1756285610374117", "article-title": "Possible clinical outcome measures for clinical trials in patients with multiple sclerosis", "volume": "3", "author": "Goldman", "year": "2010", "journal-title": "Ther Adv Neurol Disord"}], "container-title": ["European Journal of Neurology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fene.12324", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T04:33:37Z", "timestamp": 1498106017000}, "score": 41.6104, "issued": {"date-parts": [[2013, 12, 18]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2014, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1111/ene.12324", "relation": {"cites": []}, "ISSN": ["1351-5101"], "issn-type": [{"value": "1351-5101", "type": "print"}], "subject": ["Neurology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T02:23:36Z", "timestamp": 1574735016251}, "reference-count": 31, "publisher": "SAGE Publications", "issue": "13", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T00:00:00Z", "timestamp": 1482364800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100005614", "name": "Biogen", "doi-asserted-by": "publisher", "award": []}, {"name": "AbbVie Biotherapeutics Inc.", "award": []}], "content-domain": {"domain": ["journals.sagepub.com"], "crossmark-restriction": true}, "short-container-title": ["Mult Scler"], "published-print": {"date-parts": [[2017, 11]]}, "DOI": "10.1177/1352458516683266", "type": "journal-article", "created": {"date-parts": [[2017, 1, 12]], "date-time": "2017-01-12T09:40:56Z", "timestamp": 1484214056000}, "page": "1736-1747", "update-policy": "http://dx.doi.org/10.1177/sage-journals-update-policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study"], "prefix": "10.1177", "volume": "23", "author": [{"given": "Ludwig", "family": "Kappos", "sequence": "first", "affiliation": [{"name": "Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland"}]}, {"given": "Eva", "family": "Havrdova", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic"}]}, {"given": "Gavin", "family": "Giovannoni", "sequence": "additional", "affiliation": [{"name": "Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}]}, {"given": "Bhupendra O", "family": "Khatri", "sequence": "additional", "affiliation": [{"name": "Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care, Milwaukee, WI, USA"}]}, {"given": "Susan A", "family": "Gauthier", "sequence": "additional", "affiliation": [{"name": "Judith Jaffe Multiple Sclerosis Center, Weill Cornell Medical College, New York, NY, USA"}]}, {"given": "Steven J", "family": "Greenberg", "sequence": "additional", "affiliation": [{"name": "AbbVie, North Chicago, IL, USA"}]}, {"given": "Xiaojun", "family": "You", "sequence": "additional", "affiliation": [{"name": "Biogen, Cambridge, MA, USA"}]}, {"given": "Ping", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "Biogen, Cambridge, MA, USA"}]}, {"given": "Giorgio", "family": "Giannattasio", "sequence": "additional", "affiliation": [{"name": "Biogen, Zug, Switzerland"}]}], "member": "179", "published-online": {"date-parts": [[2016, 12, 22]]}, "reference": [{"key": "bibr1-1352458516683266", "author": "Giovannoni G", "volume": "4", "first-page": "329", "year": "2015", "journal-title": "Mult Scler Relat Disord", "DOI": "10.1016/j.msard.2015.04.006", "doi-asserted-by": "crossref"}, {"key": "bibr2-1352458516683266", "author": "Bevan CJ", "volume": "71", "first-page": "269", "year": "2014", "journal-title": "JAMA Neurol", "DOI": "10.1001/jamaneurol.2013.5486", "doi-asserted-by": "crossref"}, {"key": "bibr3-1352458516683266", "DOI": "10.1177/1756285614560733", "doi-asserted-by": "publisher"}, {"key": "bibr4-1352458516683266", "author": "Havrdova E", "volume": "8", "first-page": "254", "year": "2009", "journal-title": "Lancet Neurol", "DOI": "10.1016/S1474-4422(09)70021-3", "doi-asserted-by": "crossref"}, {"key": "bibr5-1352458516683266", "author": "Arnold DL", "volume": "14", "first-page": "240", "year": "2014", "journal-title": "BMC Neurol", "DOI": "10.1186/s12883-014-0240-x", "doi-asserted-by": "crossref"}, {"key": "bibr6-1352458516683266", "DOI": "10.1177/1352458513502113", "doi-asserted-by": "publisher"}, {"key": "bibr7-1352458516683266", "author": "Cohen JA", "volume": "87", "first-page": "468", "year": "2016", "journal-title": "J Neurol Neurosurg Psychiatry", "DOI": "10.1136/jnnp-2015-310597", "doi-asserted-by": "crossref"}, {"key": "bibr8-1352458516683266", "DOI": "10.1177/1352458515617249", "doi-asserted-by": "publisher"}, {"key": "bibr9-1352458516683266", "author": "Rotstein DL", "volume": "72", "first-page": "152", "year": "2015", "journal-title": "JAMA Neurol", "DOI": "10.1001/jamaneurol.2014.3537", "doi-asserted-by": "crossref"}, {"key": "bibr10-1352458516683266", "author": "Cree BA", "volume": "80", "first-page": "499", "year": "2016", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.24747", "doi-asserted-by": "crossref"}, {"key": "bibr11-1352458516683266", "DOI": "10.1080/03007995.2016.1248380", "doi-asserted-by": "publisher"}, {"key": "bibr12-1352458516683266", "DOI": "10.1177/1352458516645670", "doi-asserted-by": "publisher"}, {"key": "bibr13-1352458516683266", "author": "Nygaard GO", "volume": "10", "first-page": "e0135974", "year": "2015", "journal-title": "PLoS ONE", "DOI": "10.1371/journal.pone.0135974", "doi-asserted-by": "crossref"}, {"key": "bibr14-1352458516683266", "DOI": "10.1177/1352458516650525", "doi-asserted-by": "publisher"}, {"key": "bibr15-1352458516683266", "author": "Prosperini L", "volume": "364", "first-page": "145", "year": "2016", "journal-title": "J Neurol Sci", "DOI": "10.1016/j.jns.2016.03.025", "doi-asserted-by": "crossref"}, {"key": "bibr16-1352458516683266", "author": "Elkins J", "volume": "2", "first-page": "e65", "year": "2015", "journal-title": "Neurol Neuroimmunol Neuroinflamm", "DOI": "10.1212/NXI.0000000000000065", "doi-asserted-by": "crossref"}, {"key": "bibr17-1352458516683266", "author": "Gold R", "volume": "381", "first-page": "2167", "year": "2013", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(12)62190-4", "doi-asserted-by": "crossref"}, {"key": "bibr18-1352458516683266", "author": "Wiendl H", "volume": "9", "first-page": "394", "year": "2013", "journal-title": "Nat Rev Neurol", "DOI": "10.1038/nrneurol.2013.95", "doi-asserted-by": "crossref"}, {"key": "bibr19-1352458516683266", "author": "Kappos L", "volume": "373", "first-page": "1418", "year": "2015", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa1501481", "doi-asserted-by": "crossref"}, {"key": "bibr21-1352458516683266", "author": "Prosperini L", "volume": "323", "first-page": "104", "year": "2012", "journal-title": "J Neurol Sci", "DOI": "10.1016/j.jns.2012.08.027", "doi-asserted-by": "crossref"}, {"key": "bibr22-1352458516683266", "DOI": "10.1177/1352458515616701", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "bibr23-1352458516683266", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1093/brain/121.1.3", "volume": "121", "author": "Miller DH", "year": "1998", "journal-title": "Brain"}, {"key": "bibr24-1352458516683266", "author": "Jacobs LD", "volume": "39", "first-page": "285", "year": "1996", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410390304", "doi-asserted-by": "crossref"}, {"key": "bibr25-1352458516683266", "author": "Lublin FD", "volume": "1", "first-page": "6", "year": "2012", "journal-title": "Mult Scler Relat Disord", "DOI": "10.1016/j.msard.2011.08.001", "doi-asserted-by": "crossref"}, {"key": "bibr26-1352458516683266", "author": "Giovannoni G", "volume": "10", "first-page": "329", "year": "2011", "journal-title": "Lancet Neurol", "DOI": "10.1016/S1474-4422(11)70023-0", "doi-asserted-by": "crossref"}, {"key": "bibr27-1352458516683266", "author": "Giovannoni G", "volume": "259", "first-page": "S47", "year": "2012", "journal-title": "J Neurol", "DOI": "10.1007/s00415-011-6118-6", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "bibr28-1352458516683266", "first-page": "PD5.007", "volume": "78", "author": "Freedman MS", "year": "2012", "journal-title": "Neurology"}, {"key": "bibr29-1352458516683266", "author": "Lavery AM", "first-page": "262350", "year": "2014", "journal-title": "Mult Scler Int"}, {"key": "bibr30-1352458516683266", "author": "Polman CH", "volume": "74", "first-page": "S8", "year": "2010", "journal-title": "Neurology", "DOI": "10.1212/WNL.0b013e3181dbb571", "doi-asserted-by": "crossref"}, {"key": "bibr31-1352458516683266", "author": "Sloane JA", "volume": "72", "first-page": "835", "year": "2015", "journal-title": "JAMA Neurol", "DOI": "10.1001/jamaneurol.2015.0587", "doi-asserted-by": "crossref"}, {"key": "bibr32-1352458516683266", "author": "Imitola J", "volume": "72", "first-page": "145", "year": "2015", "journal-title": "JAMA Neurol", "DOI": "10.1001/jamaneurol.2014.3860", "doi-asserted-by": "crossref"}], "container-title": ["Multiple Sclerosis Journal"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1352458516683266", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/full-xml/10.1177/1352458516683266", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1352458516683266", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T06:51:38Z", "timestamp": 1556779898000}, "score": 41.365986, "issued": {"date-parts": [[2016, 12, 22]]}, "references-count": 31, "journal-issue": {"published-online": {"date-parts": [[2017, 4, 11]]}, "published-print": {"date-parts": [[2017, 11]]}, "issue": "13"}, "alternative-id": ["10.1177/1352458516683266"], "URL": "http://dx.doi.org/10.1177/1352458516683266", "relation": {"cites": []}, "ISSN": ["1352-4585", "1477-0970"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:25:07Z", "timestamp": 1574691907270}, "reference-count": 12, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 5, 9]], "date-time": "2015-05-09T00:00:00Z", "timestamp": 1431129600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Drugs Ther Perspect"], "published-print": {"date-parts": [[2015, 6]]}, "DOI": "10.1007/s40267-015-0216-y", "type": "journal-article", "created": {"date-parts": [[2015, 5, 8]], "date-time": "2015-05-08T07:13:33Z", "timestamp": 1431069213000}, "page": "190-195", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Peginterferon beta-1a in relapsing\u2013remitting multiple sclerosis: a guide to its use in the EU"], "prefix": "10.1007", "volume": "31", "author": [{"given": "Katherine A.", "family": "Lyseng-Williamson", "sequence": "first", "affiliation": []}, {"given": "Sheridan M.", "family": "Hoy", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 5, 9]]}, "reference": [{"issue": "10", "key": "216_CR1", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1089/jir.2010.0092", "volume": "30", "author": "DP Baker", "year": "2010", "unstructured": "Baker DP, Pepinsky RB, Brickelmaier M, et al. PEGylated interferon beta-1a: meeting an unmet medical need in the treatment of relapsing multiple sclerosis. J Interferon Cytokine Res. 2010;30(10):777\u201385.", "journal-title": "J Interferon Cytokine Res."}, {"issue": "3", "key": "216_CR2", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.2165/11596970-000000000-00000", "volume": "26", "author": "BC Kieseier", "year": "2012", "unstructured": "Kieseier BC, Calabresi PA. PEGylation of interferon-beta-1a: a promising strategy in multiple sclerosis. CNS Drugs. 2012;26(3):205\u201314.", "journal-title": "CNS Drugs."}, {"key": "216_CR3", "first-page": "101", "volume": "5", "author": "N Girouard", "year": "2011", "unstructured": "Girouard N, Soucy N. Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents. Patient Prefer Adherence. 2011;5:101\u20138.", "journal-title": "Patient Prefer Adherence."}, {"key": "216_CR4", "unstructured": "Plegridy solution for injection: summary of product characteristics. London: European Medicines Agency; 2015."}, {"key": "216_CR5", "unstructured": "Plegridy (peginterferon beta-1a), for subcutaneous injection: US prescribing information. Cambridge (MA): Biogen Idec Inc.; 2014."}, {"issue": "7", "key": "216_CR6", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1016/S1474-4422(14)70068-7", "volume": "13", "author": "PA Calabresi", "year": "2014", "unstructured": "Calabresi PA, Kieseier BC, Arnold DL, et al. Pegylated interferon beta-1a for relapsing\u2013remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Lancet Neurol. 2014;13(7):657\u201365.", "journal-title": "Lancet Neurol."}, {"key": "216_CR7", "unstructured": "Kieseier BC, Arnold DL, Balcer LJ, et al. Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE. Mult Scler. 2014. doi: 10.1177/1352458514557986 .", "DOI": "10.1177/1352458514557986", "doi-asserted-by": "crossref"}, {"key": "216_CR8", "unstructured": "Plegridy: assessment report. London: European Medicines Agency; 2014."}, {"key": "216_CR9", "unstructured": "Tolley K, Hutchinson M, Pachner A, et al. Systematic literature review and network meta-analysis of peginterferon beta-1a and injectable therapies for relapsing\u2013remitting multiple sclerosis [abstract no. P318 plus poster]. Mult Scler J. 2014;20(Suppl 1):209."}, {"key": "216_CR10", "unstructured": "Kinter ET, Guo S, Altincatal A, et al. Impact of treatment-related flu-like symptoms and injection site reactions on quality of life in patients with multiple sclerosis: ADVANCE study [abstract no. 799 plus poster]. Mult Scler J. 2014;20(Suppl 1):417."}, {"issue": "1", "key": "216_CR11", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1124/dmd.106.012419", "volume": "35", "author": "R Webster", "year": "2007", "unstructured": "Webster R, Didier E, Harris P, et al. PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies. Drug Metab Dispos. 2007;35(1):9\u201316.", "journal-title": "Drug Metab Dispos."}, {"issue": "2", "key": "216_CR12", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1007/s40263-015-0227-1", "volume": "29", "author": "SM Hoy", "year": "2015", "unstructured": "Hoy SM. Peginterferon beta-1a: a review of its use in patients with relapsing\u2013remitting multiple sclerosis. CNS Drugs. 2015;29(2):171\u20139.", "journal-title": "CNS Drugs."}], "container-title": ["Drugs & Therapy Perspectives"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s40267-015-0216-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s40267-015-0216-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s40267-015-0216-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T19:44:35Z", "timestamp": 1559504675000}, "score": 41.34021, "issued": {"date-parts": [[2015, 5, 9]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2015, 6]]}, "issue": "6"}, "alternative-id": ["216"], "URL": "http://dx.doi.org/10.1007/s40267-015-0216-y", "relation": {"cites": []}, "ISSN": ["1172-0360", "1179-1977"], "issn-type": [{"value": "1172-0360", "type": "print"}, {"value": "1179-1977", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:35:00Z", "timestamp": 1574436900847}, "reference-count": 0, "publisher": "Royal College of Physicians of Edinburgh", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JRCPE"], "published-print": {"date-parts": [[2010, 6, 14]]}, "DOI": "10.4997/jrcpe.2010.203", "type": "journal-article", "created": {"date-parts": [[2010, 6, 14]], "date-time": "2010-06-14T12:44:38Z", "timestamp": 1276519478000}, "page": "105-110", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Routine interferon-neutralising antibody testing in patients with relapsing-remitting multiple sclerosis"], "prefix": "10.4997", "volume": "40", "author": [{"given": "P", "family": "Foley", "sequence": "first", "affiliation": []}, {"given": "P", "family": "Reilly", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Coulson", "sequence": "additional", "affiliation": []}, {"given": "JI", "family": "O\u2019Riordan", "sequence": "additional", "affiliation": []}], "member": "2903", "container-title": ["The Journal of the Royal College of Physicians of Edinburgh"], "deposited": {"date-parts": [[2010, 6, 14]], "date-time": "2010-06-14T12:44:43Z", "timestamp": 1276519483000}, "score": 41.14459, "issued": {"date-parts": [[2010, 6, 14]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 6, 14]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.4997/jrcpe.2010.203", "ISSN": ["1478-2715"], "issn-type": [{"value": "1478-2715", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:39:50Z", "timestamp": 1574447990634}, "reference-count": 40, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2406, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1600-0404.1999.tb00397.x", "type": "journal-article", "created": {"date-parts": [[2010, 7, 24]], "date-time": "2010-07-24T10:02:40Z", "timestamp": 1279965760000}, "page": "283-289", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Natural interferon-\u03b2 treatment of relapsing-remitting and secondary-progressive multiple sclerosis patients. A two-year study"], "prefix": "10.1111", "volume": "100", "author": [{"given": "F.", "family": "Patti", "sequence": "first", "affiliation": []}, {"given": "M. R.", "family": "L'Episcopo", "sequence": "additional", "affiliation": []}, {"given": "M. L.", "family": "Cataldi", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Reggio", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2009, 1, 29]]}, "reference": [{"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1136/jnnp.57.1.3", "article-title": "Immunotheraphy for multiple sclerosis", "volume": "57", "author": "Hughes", "year": "1994", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB2|cit2", "first-page": "79", "article-title": "Immunosuppressive therapy in multiple sclerosis: pros and cons", "volume": "1", "author": "Noseworthy", "year": "1994", "journal-title": "Int MSJ"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1002/ana.410370105", "article-title": "The interferons: biological effects, mechanism of action, and use in multiple sclerosis", "volume": "37", "author": "Weinstock-Guttmann", "year": "1995", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "946", "DOI": "10.2165/00003495-199244060-00004", "article-title": "Interferons in multiple sclerosis", "volume": "44", "author": "Panitch", "year": "1992", "journal-title": "Drugs"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1002/ana.410270219", "article-title": "Interferon beta augments suppressor cell function in multiple sclerosis", "volume": "27", "author": "Noronha", "year": "1990", "journal-title": "Ann Neurol"}, {"issue": "Suppl. 1", "key": "10.1111/j.1600-0404.1999.tb00397.x-BIB6|cit6", "first-page": "171", "article-title": "Beta interferon prevents Hla class II antigen induction by gamma interferon in MS", "volume": "39", "author": "Panitch", "year": "1989", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB7|cit7", "first-page": "155", "article-title": "Clinical trials of interferons in multiple sclerosis", "volume": "46", "author": "Panitch", "year": "1993", "journal-title": "What have we learned? J Neuro-immunol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1146/annurev.bi.56.070187.003455", "article-title": "Interferons and their actions", "volume": "56", "author": "Pestka", "year": "1987", "journal-title": "Ann Rev Biochem"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0079-6603(08)60609-1", "article-title": "Mechanisms of the antiviral action of interferons", "volume": "35", "author": "Samuel", "year": "1988", "journal-title": "Prog Nucleic Acid Res Mol Biol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0042-6822(91)90112-O", "article-title": "Antiviral actions of interferon; interferon-regulated cellular protein and their surprisingly selective antiviral activities", "volume": "183", "author": "Samuel", "year": "1991", "journal-title": "Virology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1002/ana.410230405", "article-title": "Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro", "volume": "23", "author": "Selmaj", "year": "1988", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "2080", "DOI": "10.1212/WNL.43.10.2080", "article-title": "In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta", "volume": "43", "author": "Rudick", "year": "1993", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB13|cit13", "first-page": "2146", "article-title": "interferon acts directly on human B-lymphocytes to modulate immunoglobulin synthesis", "volume": "127", "author": "Harfast", "year": "1991", "journal-title": "J Immunol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1006/cyto.1996.0054", "article-title": "Circulating serum levels of IL-1ra in patients with relapsing-remitting multiple sclerosis are normal during remission phases, but significantly increased either during exacerbation or in response to IFN-\u03b2 treatment", "volume": "18", "author": "Nicoletti", "year": "1996", "journal-title": "Cytokine"}, {"issue": "1", "key": "10.1111/j.1600-0404.1999.tb00397.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1046/j.1365-2249.1998.00604.x", "article-title": "Blood levels of transforming growth factor-\u03b21 are elevated in both relapse-remitting and chronic progressive multiple sclerosis patients and are further augmented by treatment with interferon beta 1b", "volume": "113", "author": "Nicoletti", "year": "1998", "journal-title": "Clin Exp Immunol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1016/S0140-6736(86)92730-3", "article-title": "Multicenter double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis", "volume": "2", "author": "Jacobs", "year": "1986", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1001/archneur.1987.00520180013008", "article-title": "Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis: results of a multicenter double-blind study", "volume": "44", "author": "Jacobs", "year": "1987", "journal-title": "Arch Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1212/WNL.43.4.655", "article-title": "Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicentric, randomized, double-blind, placebo-controlled trial", "volume": "43", "author": "The IFN-\u03b2 multiple sclerosis study group.", "year": "1993", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1212/WNL.43.4.662", "article-title": "The UBC MS/MRI Study Group; and the IFN-\u03b2 Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multi-center, randomized, double-blind, placebo-controlled trial", "volume": "43", "author": "Paty", "year": "1993", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1001/archneur.1994.00540240089022", "article-title": "A brief history of the use of interferons as treatment of multiple sclerosis", "volume": "51", "author": "Jacobs", "year": "1994", "journal-title": "Arch Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1277", "DOI": "10.1212/WNL.45.7.1277", "article-title": "Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial", "volume": "45", "author": "The IFN-\u03b2 Multiple Sclerosis Study Group and the University of British Columbia MR/MRI Analysis Group.", "year": "1995", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1002/ana.410390304", "article-title": "Intramuscular interferon beta-1a for disease progression in relapsing-remitting multiple sclerosis", "volume": "39", "author": "Jacobs", "year": "1996", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB23|cit23", "first-page": "357", "article-title": "Interferon beta-1b (IFNbeta-1b) delays progression of disability in secondary progressive multiple sclerosis: results of the European multicentre study", "volume": "245", "author": "Kappos", "year": "1998", "journal-title": "J Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB24|cit24", "first-page": "S67", "article-title": "Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial", "volume": "1", "author": "Fernandez", "year": "1995", "journal-title": "Multiple Sclerosis"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1089/jir.1992.12.329", "article-title": "Double-blind randomized phase I study on the clinical tolerance and biological effects of natural and recombinant interferon-beta", "volume": "12", "author": "Liberati", "year": "1992", "journal-title": "J Interferon Res"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1002/ana.410130302", "article-title": "New diagnostic criteria for multiple sclerosis: guidelines for research protocols", "volume": "13", "author": "Poser", "year": "1983", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1212/WNL.33.11.1444", "article-title": "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", "volume": "33", "author": "Kurtzke", "year": "1983", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1159/000116943", "article-title": "Brainstem magnetic resonance imaging and evoked potential studies of symptomatic multiple sclerosis patients", "volume": "33", "author": "Comi", "year": "1993", "journal-title": "Eur Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1579", "DOI": "10.1093/brain/110.6.1579", "article-title": "The role of NMR imaging in the assessment of multiple sclerosis and isolated neurologic lesions: a quantitative study", "volume": "110", "author": "Ormerod", "year": "1987", "journal-title": "Brain"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB30|cit30", "first-page": "83", "article-title": "May there exist specific MRI findings predictive of dementia in multiple sclerosis", "volume": "10", "author": "Patti", "year": "1995", "journal-title": "Funct Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "S91", "DOI": "10.1002/ana.410360720", "article-title": "Magnetic resonance in monitoring the treatment of multiple sclerosis", "volume": "36", "author": "Miller", "year": "1994", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1077", "DOI": "10.1093/brain/116.5.1077", "article-title": "Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis", "volume": "116", "author": "Miller", "year": "1993", "journal-title": "Brain"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1136/jnnp.61.3.251", "article-title": "Magnetic resonance imaging changes with recombinant human interferon beta-1a: a short term study in relapsing-remitting multiple sclerosis", "volume": "61", "author": "Pozzilli", "year": "1996", "journal-title": "J Neurol Neuro-surg Psychiatry"}, {"issue": "Suppl. 2", "key": "10.1111/j.1600-0404.1999.tb00397.x-BIB34|cit34", "first-page": "S23", "article-title": "Multicenter clinical trial with \u201clow dose\u201d of natural beta interferon in MS patients: preliminary data", "volume": "242", "author": "Montanari", "year": "1995", "journal-title": "J Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB35|cit35", "first-page": "171", "article-title": "Multiple sclerosis: effects of intravenous natural beta-interferon on clinical neurofunction, magnetic resonance imaging plaque burden, intra-blood-brain-barrier IgG synthesis, blood and cerebrospinal fluid cellular immunology and visual evoked potentials", "volume": "22", "author": "Baumhefner", "year": "1987", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "1308", "DOI": "10.1136/jnnp.49.11.1308", "article-title": "Oligoclonal \u201cfingerprint\u201d of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta interferon", "volume": "49", "author": "Confavreux", "year": "1986", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1111/j.1468-1331.1995.tb00107.x", "article-title": "Natural interferon beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up", "volume": "2", "author": "Ghezzi", "year": "1995", "journal-title": "Eur J Neurol"}, {"issue": "Suppl. 4", "key": "10.1111/j.1600-0404.1999.tb00397.x-BIB38|cit38", "first-page": "S980", "article-title": "Side effect profile of interferon beta-1b (Betaseron)", "volume": "45", "author": "Neilley", "year": "1995", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/BF00818706", "article-title": "Problems with rating scales for multiple sclerosis: a novel approach - the CAMBS score", "volume": "240", "author": "Mumford", "year": "1993", "journal-title": "J Neurol"}, {"key": "10.1111/j.1600-0404.1999.tb00397.x-BIB40|cit40", "first-page": "103", "article-title": "Functional status measurement and medical rehabilitation outcomes", "volume": "57", "author": "Granger", "year": "1976", "journal-title": "Arch Phys Med Rehabil"}], "container-title": ["Acta Neurologica Scandinavica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0404.1999.tb00397.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 2]], "date-time": "2019-03-02T15:35:22Z", "timestamp": 1551540922000}, "score": 41.14459, "issued": {"date-parts": [[2009, 1, 29]]}, "references-count": 40, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1111/j.1600-0404.1999.tb00397.x", "relation": {"cites": []}, "ISSN": ["0001-6314", "1600-0404"], "issn-type": [{"value": "0001-6314", "type": "print"}, {"value": "1600-0404", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:07:07Z", "timestamp": 1574723227137}, "publisher-location": "Cham", "reference-count": 109, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319209692", "type": "print"}, {"value": "9783319209708", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-20970-8_8", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 28]], "date-time": "2015-08-28T14:16:47Z", "timestamp": 1440771407000}, "page": "113-133", "source": "Crossref", "is-referenced-by-count": 0, "title": ["OCT in Relapsing\u2013Remitting Multiple Sclerosis (RRMS)"], "prefix": "10.1007", "author": [{"given": "Shiv", "family": "Saidha", "sequence": "first", "affiliation": []}, {"given": "Peter A.", "family": "Calabresi", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "3", "key": "8_CR1", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1002/ana.410310317", "volume": "31", "author": "DW Anderson", "year": "1992", "unstructured": "Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol. 1992;31(3):333\u20136.", "journal-title": "Ann Neurol"}, {"issue": "4", "key": "8_CR2", "doi-asserted-by": "publisher", "first-page": "907", "DOI": "10.1212/WNL.46.4.907", "volume": "46", "author": "FD Lublin", "year": "1996", "unstructured": "Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907\u201311.", "journal-title": "Neurology"}, {"key": "8_CR3", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1111/j.1749-6632.2011.06272.x", "volume": "1247", "author": "S Saidha", "year": "2012", "unstructured": "Saidha S, Eckstein C, Calabresi PA. New and emerging disease modifying therapies for multiple sclerosis. Ann N Y Acad Sci. 2012;1247:117\u201337.", "journal-title": "Ann N Y Acad Sci"}, {"key": "8_CR4", "author": "J Prineas", "first-page": "289", "year": "2001", "unstructured": "Prineas J. Pathology of multiple sclerosis. In: Cook S, editor. Handbook of multiple sclerosis. New York: Marcel Dekker; 2001. p. 289\u2013324.", "volume-title": "Handbook of multiple sclerosis"}, {"issue": "9", "key": "8_CR5", "doi-asserted-by": "publisher", "first-page": "942", "DOI": "10.1056/NEJMra052130", "volume": "354", "author": "EM Frohman", "year": "2006", "unstructured": "Frohman EM, Racke MK, Raine CS. Multiple sclerosis \u2013 the plaque and its pathogenesis. N Engl J Med. 2006;354(9):942\u201355.", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "8_CR6", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1111/j.1365-2990.1981.tb00087.x", "volume": "7", "author": "IV Allen", "year": "1981", "unstructured": "Allen IV. The pathology of multiple sclerosis \u2013 fact, fiction and hypothesis. Neuropathol Appl Neurobiol. 1981;7(3):169\u201382.", "journal-title": "Neuropathol Appl Neurobiol"}, {"issue": "5", "key": "8_CR7", "doi-asserted-by": "publisher", "first-page": "720", "DOI": "10.1016/S0161-6420(92)31905-0", "volume": "99", "author": "J Guy", "year": "1992", "unstructured": "Guy J, Fitzsimmons J, Ellis EA, Beck B, Mancuso A. Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy. Ophthalmology. 1992;99(5):720\u20135.", "journal-title": "Ophthalmology."}, {"issue": "1", "key": "8_CR8", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1001/jamaneurol.2013.573", "volume": "70", "author": "S Saidha", "year": "2013", "unstructured": "Saidha S, Sotirchos ES, Oh J, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013;70(1):34\u201343.", "journal-title": "JAMA Neurol"}, {"issue": "12", "key": "8_CR9", "doi-asserted-by": "publisher", "first-page": "664", "DOI": "10.1038/ncpneuro0950", "volume": "4", "author": "EM Frohman", "year": "2008", "unstructured": "Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. 2008;4(12):664\u201375.", "journal-title": "Nat Clin Pract Neurol"}, {"issue": "2", "key": "8_CR10", "first-page": "33", "volume": "2", "author": "S Saidha", "year": "2010", "unstructured": "Saidha S, Eckstein C, Ratchford JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML \u2013 Mult Scler. 2010;2(2):33\u201343.", "journal-title": "CML \u2013 Mult Scler"}, {"key": "8_CR11", "first-page": "211", "volume": "27", "author": "O Marburg", "year": "1906", "unstructured": "Marburg O. Die sogennate akute multiple sklerose. Jahrb Psychiatrie. 1906;27:211\u2013312.", "journal-title": "Jahrb Psychiatrie"}, {"key": "8_CR12", "doi-asserted-by": "publisher", "first-page": "1289", "DOI": "10.1001/archneurpsyc.1936.02260060131011", "volume": "35", "author": "T Putnam", "year": "1936", "unstructured": "Putnam T. Studies in multiple sclerosis. Arch Neurol Psychol. 1936;35:1289\u2013308.", "journal-title": "Arch Neurol Psychol"}, {"issue": "5", "key": "8_CR13", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1002/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4", "volume": "46", "author": "JH Waesberghe van", "year": "1999", "unstructured": "van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46(5):747\u201354.", "journal-title": "Ann Neurol"}, {"issue": "1", "key": "8_CR14", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1001/archneur.58.1.65", "volume": "58", "author": "N Stefano De", "year": "2001", "unstructured": "De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol. 2001;58(1):65\u201370.", "journal-title": "Arch Neurol"}, {"issue": "9313", "key": "8_CR15", "doi-asserted-by": "publisher", "first-page": "1221", "DOI": "10.1016/S0140-6736(02)08220-X", "volume": "359", "author": "A Compston", "year": "2002", "unstructured": "Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221\u201331.", "journal-title": "Lancet"}, {"issue": "2", "key": "8_CR16", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1602/neurorx.1.2.284", "volume": "1", "author": "DH Miller", "year": "2004", "unstructured": "Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx. 2004;1(2):284\u201394.", "journal-title": "NeuroRx"}, {"issue": "5", "key": "8_CR17", "doi-asserted-by": "publisher", "first-page": "632", "DOI": "10.1177/1352458509102617", "volume": "15", "author": "A Minneboo", "year": "2009", "unstructured": "Minneboo A, Uitdehaag BM, Jongen P, et al. Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Mult Scler. 2009;15(5):632\u20137.", "journal-title": "Mult Scler"}, {"issue": "9", "key": "8_CR18", "doi-asserted-by": "publisher", "first-page": "1212", "DOI": "10.1007/s00415-006-0503-6", "volume": "254", "author": "M Calabrese", "year": "2007", "unstructured": "Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol. 2007;254(9):1212\u201320.", "journal-title": "J Neurol"}, {"issue": "9", "key": "8_CR19", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1001/archneurol.2009.174", "volume": "66", "author": "M Calabrese", "year": "2009", "unstructured": "Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144\u201350.", "journal-title": "Arch Neurol"}, {"issue": "6", "key": "8_CR20", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1177/135245859700300601", "volume": "3", "author": "JA Rawes", "year": "1997", "unstructured": "Rawes JA, Calabrese VP, Khan OA, DeVries GH. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Mult Scler. 1997;3(6):363\u20139.", "journal-title": "Mult Scler"}, {"issue": "3", "key": "8_CR21", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1080/01616412.1996.11740410", "volume": "18", "author": "MC Madigan", "year": "1996", "unstructured": "Madigan MC, Rao NS, Tenhula WN, Sadun AA. Preliminary morphometric study of tumor necrosis factor-alpha (TNF alpha)-induced rabbit optic neuropathy. Neurol Res. 1996;18(3):233\u20136.", "journal-title": "Neurol Res"}, {"issue": "3", "key": "8_CR22", "doi-asserted-by": "publisher", "first-page": "208", "DOI": "10.1016/j.exer.2008.05.017", "volume": "87", "author": "KS Shindler", "year": "2008", "unstructured": "Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008;87(3):208\u201313.", "journal-title": "Exp Eye Res"}, {"issue": "Pt 5", "key": "8_CR23", "doi-asserted-by": "publisher", "first-page": "1175", "DOI": "10.1093/brain/awp070", "volume": "132", "author": "JM Frischer", "year": "2009", "unstructured": "Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132(Pt 5):1175\u201389.", "journal-title": "Brain"}, {"issue": "3", "key": "8_CR24", "first-page": "211", "volume": "3", "author": "D Toussaint", "year": "1983", "unstructured": "Toussaint D, Perier O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983;3(3):211\u201320.", "journal-title": "J Clin Neuroophthalmol"}, {"issue": "6 PT 2", "key": "8_CR25", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1212/WNL.26.6_Part_2.26", "volume": "26", "author": "F Ikuta", "year": "1976", "unstructured": "Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology. 1976;26(6 PT 2):26\u20138.", "journal-title": "Neurology"}, {"issue": "1", "key": "8_CR26", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/j.pathophys.2010.04.009", "volume": "18", "author": "EV Burton", "year": "2011", "unstructured": "Burton EV, Greenberg BM, Frohman EM. Optic neuritis: a mechanistic view. Pathophysiology. 2011;18(1):81\u201392.", "journal-title": "Pathophysiology"}, {"issue": "2", "key": "8_CR27", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0054722", "volume": "8", "author": "A Penta di", "year": "2013", "unstructured": "di Penta A, Moreno B, Reix S, et al. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One. 2013;8(2), e54722.", "journal-title": "PLoS One"}, {"issue": "4", "key": "8_CR28", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.1016/S1474-4422(02)00102-3", "volume": "1", "author": "KJ Smith", "year": "2002", "unstructured": "Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002;1(4):232\u201341.", "journal-title": "Lancet Neurol"}, {"issue": "13", "key": "8_CR29", "doi-asserted-by": "publisher", "first-page": "938", "DOI": "10.1056/NEJM200009283431307", "volume": "343", "author": "JH Noseworthy", "year": "2000", "unstructured": "Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938\u201352.", "journal-title": "N Engl J Med"}, {"issue": "Pt 12", "key": "8_CR30", "doi-asserted-by": "publisher", "first-page": "2279", "DOI": "10.1093/brain/122.12.2279", "volume": "122", "author": "C Lucchinetti", "year": "1999", "unstructured": "Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999;122(Pt 12):2279\u201395.", "journal-title": "Brain"}, {"issue": "Pt 4", "key": "8_CR31", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1093/brain/113.4.953", "volume": "113", "author": "WM Carroll", "year": "1990", "unstructured": "Carroll WM, Jennings AR, Mastaglia FL. The origin of remyelinating oligodendrocytes in antiserum-mediated demyelinative optic neuropathy. Brain. 1990;113(Pt 4):953\u201373.", "journal-title": "Brain"}, {"issue": "4", "key": "8_CR32", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1002/jnr.490360407", "volume": "36", "author": "R Reynolds", "year": "1993", "unstructured": "Reynolds R, Wilkin GP. Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: localisation of GD3 ganglioside immunoreactivity. J Neurosci Res. 1993;36(4):405\u201322.", "journal-title": "J Neurosci Res"}, {"issue": "Pt 12", "key": "8_CR33", "doi-asserted-by": "publisher", "first-page": "2221", "DOI": "10.1093/brain/121.12.2221", "volume": "121", "author": "N Scolding", "year": "1998", "unstructured": "Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain. 1998;121(Pt 12):2221\u20138.", "journal-title": "Brain"}, {"issue": "23", "key": "8_CR34", "doi-asserted-by": "publisher", "first-page": "3821", "DOI": "10.1016/j.febslet.2011.03.048", "volume": "585", "author": "KA Hanafy", "year": "2011", "unstructured": "Hanafy KA, Sloane JA. Regulation of remyelination in multiple sclerosis. FEBS Lett. 2011;585(23):3821\u20138.", "journal-title": "FEBS Lett"}, {"issue": "20", "key": "8_CR35", "doi-asserted-by": "publisher", "first-page": "1957", "DOI": "10.1016/j.cub.2012.08.025", "volume": "22", "author": "LM Wu", "year": "2012", "unstructured": "Wu LM, Williams A, Delaney A, Sherman DL, Brophy PJ. Increasing internodal distance in myelinated nerves accelerates nerve conduction to a flat maximum. Curr Biol. 2012;22(20):1957\u201361.", "journal-title": "Curr Biol"}, {"issue": "Pt 3", "key": "8_CR36", "doi-asserted-by": "publisher", "first-page": "681", "DOI": "10.1093/brain/116.3.681", "volume": "116", "author": "JW Prineas", "year": "1993", "unstructured": "Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain. 1993;116(Pt 3):681\u201393.", "journal-title": "Brain"}, {"issue": "1", "key": "8_CR37", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1016/j.ajpath.2012.03.030", "volume": "181", "author": "A Kanamori", "year": "2012", "unstructured": "Kanamori A, Catrinescu MM, Belisle JM, Costantino S, Levin LA. Retrograde and wallerian axonal degeneration occur synchronously after retinal ganglion cell axotomy. Am J Pathol. 2012;181(1):62\u201373.", "journal-title": "Am J Pathol"}, {"issue": "Pt 9", "key": "8_CR38", "doi-asserted-by": "publisher", "first-page": "1813", "DOI": "10.1093/brain/124.9.1813", "volume": "124", "author": "N Evangelou", "year": "2001", "unstructured": "Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124(Pt 9):1813\u201320.", "journal-title": "Brain"}, {"issue": "3", "key": "8_CR39", "first-page": "121", "volume": "19", "author": "R Fairless", "year": "2012", "unstructured": "Fairless R, Williams SK, Hoffmann DB, et al. Preclinical retinal neurodegeneration in a model of multiple sclerosis: the journal of neuroscience 2012; 32(16):5585\u20135597. Ann Neurosci. 2012;19(3):121\u20132.", "journal-title": "Ann Neurosci"}, {"issue": "5", "key": "8_CR40", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1097/00006982-199414050-00010", "volume": "14", "author": "JB Kerrison", "year": "1994", "unstructured": "Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina. 1994;14(5):445\u201351.", "journal-title": "Retina"}, {"issue": "6", "key": "8_CR41", "doi-asserted-by": "publisher", "first-page": "1591", "DOI": "10.1093/brain/awq080", "volume": "133", "author": "AJ Green", "year": "2010", "unstructured": "Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133(6):1591\u2013601.", "journal-title": "Brain"}, {"issue": "3", "key": "8_CR42", "doi-asserted-by": "publisher", "first-page": "202", "DOI": "10.1136/jnnp.20.3.202", "volume": "20", "author": "F Goldby", "year": "1957", "unstructured": "Goldby F. A note on transneuronal atrophy in the human lateral geniculate body. J Neurol Neurosurg Psychiatry. 1957;20(3):202\u20137.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "8_CR43", "doi-asserted-by": "publisher", "first-page": "402", "DOI": "10.1136/jnnp.26.5.402", "volume": "26", "author": "JM VanBuren", "year": "1963", "unstructured": "VanBuren JM. Trans-synaptic retrograde degeneration in the visual system of primates. J Neurol Neurosurg Psychiatry. 1963;26:402\u20139.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "8_CR44", "first-page": "66", "volume": "64", "author": "JP Gills Jr", "year": "1966", "unstructured": "Gills Jr JP, Wadsworth JA. Degeneration of the inner nuclear layer of the retina following lesions of the optic nerve. Trans Am Ophthalmol Soc. 1966;64:66\u201388.", "journal-title": "Trans Am Ophthalmol Soc"}, {"issue": "6", "key": "8_CR45", "first-page": "555", "volume": "5", "author": "JP Gills Jr", "year": "1966", "unstructured": "Gills Jr JP. Electroretinographic abnormalities and advanced multiple sclerosis. Invest Ophthalmol. 1966;5(6):555\u20139.", "journal-title": "Invest Ophthalmol"}, {"issue": "6", "key": "8_CR46", "first-page": "796", "volume": "22", "author": "WW Dawson", "year": "1982", "unstructured": "Dawson WW, Maida TM, Rubin ML. Human pattern-evoked retinal responses are altered by optic atrophy. Invest Ophthalmol Vis Sci. 1982;22(6):796\u2013803.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "9", "key": "8_CR47", "doi-asserted-by": "publisher", "first-page": "1127", "DOI": "10.1016/S0161-6420(83)80057-8", "volume": "90", "author": "W Seiple", "year": "1983", "unstructured": "Seiple W, Price MJ, Kupersmith M, Siegel IM, Carr RE. The pattern electroretinogram in optic nerve disease. Ophthalmology. 1983;90(9):1127\u201332.", "journal-title": "Ophthalmology"}, {"issue": "5", "key": "8_CR48", "doi-asserted-by": "publisher", "first-page": "644", "DOI": "10.1212/WNL.35.5.644", "volume": "35", "author": "D Kaufman", "year": "1985", "unstructured": "Kaufman D, Celesia GG. Simultaneous recording of pattern electroretinogram and visual evoked responses in neuro-ophthalmologic disorders. Neurology. 1985;35(5):644\u201351.", "journal-title": "Neurology"}, {"issue": "1", "key": "8_CR49", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0168-5597(89)90045-2", "volume": "74", "author": "D Papakostopoulos", "year": "1989", "unstructured": "Papakostopoulos D, Fotiou F, Hart JC, Banerji NK. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol. 1989;74(1):1\u201310.", "journal-title": "Electroencephalogr Clin Neurophysiol"}, {"issue": "2", "key": "8_CR50", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1007/s10633-006-9022-0", "volume": "113", "author": "F Forooghian", "year": "2006", "unstructured": "Forooghian F, Sproule M, Westall C, et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol. 2006;113(2):123\u201332.", "journal-title": "Doc Ophthalmol"}, {"issue": "5", "key": "8_CR51", "first-page": "335", "volume": "47", "author": "CW Rucker", "year": "1972", "unstructured": "Rucker CW. Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc. 1972;47(5):335\u201340.", "journal-title": "Mayo Clin Proc"}, {"issue": "1", "key": "8_CR52", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1111/j.1755-3768.1985.tb05221.x", "volume": "63", "author": "T Engell", "year": "1985", "unstructured": "Engell T, Jensen OA, Klinken L. Periphlebitis retinae in multiple sclerosis. A histopathological study of two cases. Acta Ophthalmol (Copenh). 1985;63(1):83\u20138.", "journal-title": "Acta Ophthalmol (Copenh)"}, {"issue": "5", "key": "8_CR53", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1111/j.1600-0404.1984.tb07815.x", "volume": "69", "author": "T Engell", "year": "1984", "unstructured": "Engell T, Hvidberg A, Uhrenholdt A. Multiple sclerosis: periphlebitis retinalis et cerebro-spinalis. A correlation between periphlebitis retinalis and abnormal technetium brain scintigraphy. Acta Neurol Scand. 1984;69(5):293\u20137.", "journal-title": "Acta Neurol Scand"}, {"issue": "18", "key": "8_CR54", "doi-asserted-by": "publisher", "first-page": "1488", "DOI": "10.1212/01.wnl.0000260612.51849.ed", "volume": "68", "author": "J Sepulcre", "year": "2007", "unstructured": "Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007;68(18):1488\u201394.", "journal-title": "Neurology"}, {"issue": "10", "key": "8_CR55", "doi-asserted-by": "publisher", "first-page": "877", "DOI": "10.1212/WNL.0b013e3182a3525e", "volume": "81", "author": "S Ortiz-Perez", "year": "2013", "unstructured": "Ortiz-Perez S, Martinez-Lapiscina EH, Gabilondo I, et al. Retinal periphlebitis is associated with multiple sclerosis severity. Neurology. 2013;81(10):877\u201381.", "journal-title": "Neurology"}, {"issue": "Pt 2", "key": "8_CR56", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1093/brain/110.2.405", "volume": "110", "author": "S Lightman", "year": "1987", "unstructured": "Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain. 1987;110(Pt 2):405\u201314.", "journal-title": "Brain"}, {"issue": "6", "key": "8_CR57", "doi-asserted-by": "publisher", "first-page": "812", "DOI": "10.1016/j.ajo.2007.08.023", "volume": "144", "author": "MJ Donaldson", "year": "2007", "unstructured": "Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144(6):812\u20137.", "journal-title": "Am J Ophthalmol"}, {"issue": "5035", "key": "8_CR58", "doi-asserted-by": "publisher", "first-page": "1178", "DOI": "10.1126/science.1957169", "volume": "254", "author": "D Huang", "year": "1991", "unstructured": "Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254(5035):1178\u201381.", "journal-title": "Science"}, {"issue": "7", "key": "8_CR59", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1097/00006324-200007000-00009", "volume": "77", "author": "P Hrynchak", "year": "2000", "unstructured": "Hrynchak P, Simpson T. Optical coherence tomography: an introduction to the technique and its use. Optom Vis Sci. 2000;77(7):347\u201356.", "journal-title": "Optom Vis Sci"}, {"issue": "2", "key": "8_CR60", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1364/AO.42.000227", "volume": "42", "author": "IJ Hsu", "year": "2003", "unstructured": "Hsu IJ, Sun CW, Lu CW, Yang CC, Chiang CP, Lin CW. Resolution improvement with dispersion manipulation and a retrieval algorithm in optical coherence tomography. Appl Optics. 2003;42(2):227\u201334.", "journal-title": "Appl Optics"}, {"issue": "1", "key": "8_CR61", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/j.ophtha.2006.06.045", "volume": "114", "author": "FC Moura", "year": "2007", "unstructured": "Moura FC, Medeiros FA, Monteiro ML. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography. Ophthalmology. 2007;114(1):175\u201381.", "journal-title": "Ophthalmology"}, {"issue": "11", "key": "8_CR62", "doi-asserted-by": "publisher", "first-page": "1366", "DOI": "10.1001/archneurol.2009.230", "volume": "66", "author": "BM Burkholder", "year": "2009", "unstructured": "Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009;66(11):1366\u201372.", "journal-title": "Arch Neurol"}, {"issue": "3", "key": "8_CR63", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1364/OL.13.000186", "volume": "13", "author": "AF Fercher", "year": "1988", "unstructured": "Fercher AF, Mengedoht K, Werner W. Eye-length measurement by interferometry with partially coherent light. Opt Lett. 1988;13(3):186\u20138.", "journal-title": "Opt Lett"}, {"issue": "3", "key": "8_CR64", "first-page": "616", "volume": "32", "author": "CK Hitzenberger", "year": "1991", "unstructured": "Hitzenberger CK. Optical measurement of the axial eye length by laser Doppler interferometry. Invest Ophthalmol Vis Sci. 1991;32(3):616\u201324.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "11", "key": "8_CR65", "doi-asserted-by": "publisher", "first-page": "2071", "DOI": "10.1038/eye.2008.363", "volume": "23", "author": "R Forte", "year": "2009", "unstructured": "Forte R, Cennamo GL, Finelli ML, de Crecchio G. Comparison of time domain stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye (Lond). 2009;23(11):2071\u20138.", "journal-title": "Eye (Lond)"}, {"issue": "21", "key": "8_CR66", "doi-asserted-by": "publisher", "first-page": "2067", "DOI": "10.1364/OL.28.002067", "volume": "28", "author": "JF Boer de", "year": "2003", "unstructured": "de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28(21):2067\u20139.", "journal-title": "Opt Lett"}, {"issue": "11", "key": "8_CR67", "doi-asserted-by": "publisher", "first-page": "2404", "DOI": "10.1364/OPEX.12.002404", "volume": "12", "author": "M Wojtkowski", "year": "2004", "unstructured": "Wojtkowski M, Srinivasan V, Ko T, Fujimoto J, Kowalczyk A, Duker J. Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express. 2004;12(11):2404\u201322.", "journal-title": "Opt Express"}, {"issue": "5", "key": "8_CR68", "doi-asserted-by": "publisher", "first-page": "480", "DOI": "10.1364/OL.29.000480", "volume": "29", "author": "N Nassif", "year": "2004", "unstructured": "Nassif N, Cense B, Park BH, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004;29(5):480\u20132.", "journal-title": "Opt Lett"}, {"issue": "8", "key": "8_CR69", "doi-asserted-by": "publisher", "first-page": "889", "DOI": "10.1364/OE.11.000889", "volume": "11", "author": "R Leitgeb", "year": "2003", "unstructured": "Leitgeb R, Hitzenberger C, Fercher A. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express. 2003;11(8):889\u201394.", "journal-title": "Opt Express"}, {"issue": "7", "key": "8_CR70", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1177/1352458510371640", "volume": "16", "author": "SB Syc", "year": "2010", "unstructured": "Syc SB, Warner CV, Hiremath GS, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler. 2010;16(7):829\u201339.", "journal-title": "Mult Scler"}, {"issue": "Pt 2", "key": "8_CR71", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1093/brain/awq346", "volume": "134", "author": "S Saidha", "year": "2011", "unstructured": "Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(Pt 2):518\u201333.", "journal-title": "Brain"}, {"issue": "9", "key": "8_CR72", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1016/S1474-4422(10)70168-X", "volume": "9", "author": "A Petzold", "year": "2010", "unstructured": "Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9(9):921\u201332.", "journal-title": "Lancet Neurol"}, {"issue": "11", "key": "8_CR73", "first-page": "2520", "volume": "40", "author": "V Parisi", "year": "1999", "unstructured": "Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40(11):2520\u20137.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "3", "key": "8_CR74", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1002/ana.20575", "volume": "58", "author": "SA Trip", "year": "2005", "unstructured": "Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383\u201391.", "journal-title": "Ann Neurol"}, {"issue": "Pt 2", "key": "8_CR75", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1093/brain/awr264", "volume": "135", "author": "SB Syc", "year": "2012", "unstructured": "Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135(Pt 2):521\u201333.", "journal-title": "Brain"}, {"issue": "12", "key": "8_CR76", "doi-asserted-by": "publisher", "first-page": "1449", "DOI": "10.1177/1352458511418630", "volume": "17", "author": "S Saidha", "year": "2011", "unstructured": "Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011;17(12):1449\u201363.", "journal-title": "Mult Scler"}, {"issue": "6", "key": "8_CR77", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1002/ana.20851", "volume": "59", "author": "F Costello", "year": "2006", "unstructured": "Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963\u20139.", "journal-title": "Ann Neurol"}, {"issue": "2", "key": "8_CR78", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1016/j.ophtha.2005.10.040", "volume": "113", "author": "JB Fisher", "year": "2006", "unstructured": "Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113(2):324\u201332.", "journal-title": "Ophthalmology"}, {"issue": "6", "key": "8_CR79", "first-page": "749", "volume": "67", "author": "LS Talman", "year": "2010", "unstructured": "Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749\u201360.", "journal-title": "Ann Neurol"}, {"issue": "11", "key": "8_CR80", "doi-asserted-by": "publisher", "first-page": "1577", "DOI": "10.1136/bjo.2010.199232", "volume": "95", "author": "E Garcia-Martin", "year": "2011", "unstructured": "Garcia-Martin E, Pueyo V, Almarcegui C, et al. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol. 2011;95(11):1577\u201382.", "journal-title": "Br J Ophthalmol"}, {"issue": "7", "key": "8_CR81", "doi-asserted-by": "publisher", "first-page": "1083", "DOI": "10.1007/s00415-010-5467-x", "volume": "257", "author": "AP Henderson", "year": "2010", "unstructured": "Henderson AP, Trip SA, Schlottmann PG, et al. A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol. 2010;257(7):1083\u201391.", "journal-title": "J Neurol"}, {"issue": "5", "key": "8_CR82", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0019843", "volume": "6", "author": "N Serbecic", "year": "2011", "unstructured": "Serbecic N, Aboul-Enein F, Beutelspacher SC, et al. High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One. 2011;6(5), e19843.", "journal-title": "PLoS One"}, {"issue": "1", "key": "8_CR83", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1212/WNL.0b013e31827b1a1c", "volume": "80", "author": "JN Ratchford", "year": "2013", "unstructured": "Ratchford JN, Saidha S, Sotirchos ES, et al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 2013;80(1):47\u201354.", "journal-title": "Neurology"}, {"issue": "12", "key": "8_CR84", "doi-asserted-by": "publisher", "first-page": "5773", "DOI": "10.1167/iovs.07-0834", "volume": "48", "author": "FC Gundogan", "year": "2007", "unstructured": "Gundogan FC, Demirkaya S, Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? \u2013 A structural and functional evaluation. Invest Ophthalmol Vis Sci. 2007;48(12):5773\u201381.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "Pt 6", "key": "8_CR85", "doi-asserted-by": "publisher", "first-page": "1786", "DOI": "10.1093/brain/aws098", "volume": "135", "author": "JM Gelfand", "year": "2012", "unstructured": "Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012;135(Pt 6):1786\u201393.", "journal-title": "Brain"}, {"issue": "11", "key": "8_CR86", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1016/S1474-4422(12)70213-2", "volume": "11", "author": "S Saidha", "year": "2012", "unstructured": "Saidha S, Sotirchos ES, Ibrahim MA, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012;11(11):963\u201372.", "journal-title": "Lancet Neurol"}, {"issue": "3", "key": "8_CR87", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1097/IAE.0b013e3181cd4803", "volume": "30", "author": "M Brar", "year": "2010", "unstructured": "Brar M, Yuson R, Kozak I, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina. 2010;30(3):383\u20139.", "journal-title": "Retina"}, {"issue": "15", "key": "8_CR88", "doi-asserted-by": "publisher", "first-page": "1406", "DOI": "10.1212/WNL.0b013e31828c2f7a", "volume": "80", "author": "ES Sotirchos", "year": "2013", "unstructured": "Sotirchos ES, Saidha S, Byraiah G, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology. 2013;80(15):1406\u201314.", "journal-title": "Neurology"}, {"issue": "8", "key": "8_CR89", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0071145", "volume": "8", "author": "F Kaufhold", "year": "2013", "unstructured": "Kaufhold F, Zimmermann H, Schneider E, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One. 2013;8(8), e71145.", "journal-title": "PLoS One"}, {"issue": "Pt 7", "key": "8_CR90", "doi-asserted-by": "publisher", "DOI": "10.1093/brain/awt014", "volume": "136", "author": "P Barboni", "year": "2013", "unstructured": "Barboni P, Carelli V, Savini G, Carbonelli M, La Morgia C, Sadun AA. Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. 2013;136(Pt 7), e239.", "journal-title": "Brain"}, {"issue": "10", "key": "8_CR91", "doi-asserted-by": "publisher", "first-page": "2133", "DOI": "10.1097/IAE.0b013e31828e68d0", "volume": "33", "author": "B Wolff", "year": "2013", "unstructured": "Wolff B, Basdekidou C, Vasseur V, Mauget-Faysse M, Sahel JA, Vignal C. Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina. 2013;33(10):2133\u20138.", "journal-title": "Retina"}, {"issue": "1", "key": "8_CR92", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1212/WNL.0000000000000545", "volume": "83", "author": "AU Brandt", "year": "2014", "unstructured": "Brandt AU, Oberwahrenbrock T, Kadas EM, Lagreze WA, Paul F. Dynamic formation of macular microcysts independent of vitreous traction changes. Neurology. 2014;83(1):73\u20137.", "journal-title": "Neurology"}, {"issue": "9157", "key": "8_CR93", "doi-asserted-by": "publisher", "first-page": "964", "DOI": "10.1016/S0140-6736(98)03053-0", "volume": "353", "author": "L Kappos", "year": "1999", "unstructured": "Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-Analysis Group. Lancet. 1999;353(9157):964\u20139.", "journal-title": "Lancet."}, {"issue": "9", "key": "8_CR94", "doi-asserted-by": "publisher", "first-page": "1412", "DOI": "10.1212/01.WNL.0000036271.49066.06", "volume": "59", "author": "E Fisher", "year": "2002", "unstructured": "Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology. 2002;59(9):1412\u201320.", "journal-title": "Neurology"}, {"issue": "1", "key": "8_CR95", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1002/ana.24018", "volume": "75", "author": "MP Sormani", "year": "2014", "unstructured": "Sormani MP, Arnold DL, De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol. 2014;75(1):43\u20139.", "journal-title": "Ann Neurol"}, {"issue": "6", "key": "8_CR96", "doi-asserted-by": "publisher", "first-page": "679", "DOI": "10.1177/1352458506070823", "volume": "12", "author": "JH Simon", "year": "2006", "unstructured": "Simon JH. Brain atrophy in multiple sclerosis: what we know and would like to know. Mult Scler. 2006;12(6):679\u201387.", "journal-title": "Mult Scler"}, {"issue": "2", "key": "8_CR97", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1002/msj.20247", "volume": "78", "author": "M Inglese", "year": "2011", "unstructured": "Inglese M, Oesingmann N, Casaccia P, Fleysher L. Progressive multiple sclerosis and gray matter pathology: an MRI perspective. Mt Sinai J Med. 2011;78(2):258\u201367.", "journal-title": "Mt Sinai J Med"}, {"issue": "10", "key": "8_CR98", "doi-asserted-by": "publisher", "first-page": "1296", "DOI": "10.1177/1352458514541509", "volume": "20", "author": "S Saidha", "year": "2014", "unstructured": "Saidha S, Calabresi PA. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes. Mult Scler. 2014;20(10):1296\u20138.", "journal-title": "Mult Scler"}, {"issue": "16", "key": "8_CR99", "doi-asserted-by": "publisher", "first-page": "1603", "DOI": "10.1212/01.wnl.0000295995.46586.ae", "volume": "69", "author": "E Gordon-Lipkin", "year": "2007", "unstructured": "Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69(16):1603\u20139.", "journal-title": "Neurology"}, {"issue": "1\u20132", "key": "8_CR100", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1016/j.jns.2007.10.020", "volume": "268", "author": "E Grazioli", "year": "2008", "unstructured": "Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268(1\u20132):12\u20137.", "journal-title": "J Neurol Sci"}, {"issue": "10", "key": "8_CR101", "doi-asserted-by": "publisher", "first-page": "1555", "DOI": "10.1007/s00415-008-0985-5", "volume": "255", "author": "M Siger", "year": "2008", "unstructured": "Siger M, Dziegielewski K, Jasek L, et al. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol. 2008;255(10):1555\u201360.", "journal-title": "J Neurol"}, {"issue": "4", "key": "8_CR102", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0018132", "volume": "6", "author": "J Dorr", "year": "2011", "unstructured": "Dorr J, Wernecke KD, Bock M, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011;6(4), e18132.", "journal-title": "PLoS One"}, {"issue": "4", "key": "8_CR103", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0018019", "volume": "6", "author": "CF Pfueller", "year": "2011", "unstructured": "Pfueller CF, Brandt AU, Schubert F, et al. Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One. 2011;6(4), e18019.", "journal-title": "PLoS One"}, {"issue": "8", "key": "8_CR104", "doi-asserted-by": "publisher", "first-page": "998", "DOI": "10.1001/archneurol.2009.107", "volume": "66", "author": "DS Reich", "year": "2009", "unstructured": "Reich DS, Smith SA, Gordon-Lipkin EM, et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol. 2009;66(8):998\u20131006.", "journal-title": "Arch Neurol"}, {"issue": "5", "key": "8_CR105", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1111/ene.12070", "volume": "20", "author": "KL Young", "year": "2013", "unstructured": "Young KL, Brandt AU, Petzold A, et al. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol. 2013;20(5):803\u201311.", "journal-title": "Eur J Neurol"}, {"issue": "4", "key": "8_CR106", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1177/1352458512457844", "volume": "19", "author": "H Zimmermann", "year": "2013", "unstructured": "Zimmermann H, Freing A, Kaufhold F, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler. 2013;19(4):443\u201350.", "journal-title": "Mult Scler"}, {"issue": "1", "key": "8_CR107", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1002/ana.24030", "volume": "75", "author": "I Gabilondo", "year": "2014", "unstructured": "Gabilondo I, Martinez-Lapiscina EH, Martinez-Heras E, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014;75(1):98\u2013107.", "journal-title": "Ann Neurol"}, {"issue": "10", "key": "8_CR108", "doi-asserted-by": "publisher", "first-page": "1302", "DOI": "10.1177/1352458514545144", "volume": "20", "author": "M Hutchinson", "year": "2014", "unstructured": "Hutchinson M. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: commentary. Mult Scler. 2014;20(10):1302\u20133.", "journal-title": "Mult Scler"}, {"issue": "2", "key": "8_CR109", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1002/ana.23573", "volume": "72", "author": "KW Suhs", "year": "2012", "unstructured": "Suhs KW, Hein K, Sattler MB, et al. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol. 2012;72(2):199\u2013210.", "journal-title": "Ann Neurol"}], "container-title": ["Optical Coherence Tomography in Multiple Sclerosis"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-20970-8_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T19:52:10Z", "timestamp": 1559245930000}, "score": 40.850246, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319209692", "9783319209708"], "references-count": 109, "URL": "http://dx.doi.org/10.1007/978-3-319-20970-8_8", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}